<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="paragangliomas" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">paragangliomas</book-part-id>
      <title-group>
        <title>Hereditary Paraganglioma-Pheochromocytoma Syndromes</title>
        <alt-title alt-title-type="alt-title">Synonyms: Familial Glomus Tumors, Familial Nonchromaffin Paragangliomas</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kirmani</surname>
            <given-names>Salman</given-names>
          </name>
          <degrees>MBBS</degrees>
          <aff>Associate Professor of Pediatrics<break/>Chair, Department of Pediatrics &#x00026; Child Health<break/>Aga Khan Unversity<break/>Karachi, Pakistan</aff>
          <email>salman.kirmani@aku.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Young</surname>
            <given-names>William F</given-names>
          </name>
          <degrees>MD, MSc</degrees>
          <aff>Professor of Medicine<break/>Chair, Division of Endocrinology<break/>Mayo Clinic<break/>Rochester, Minnesota</aff>
          <email>young.william@mayo.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>21</day>
          <month>5</month>
          <year>2008</year>
        </date>
        <date date-type="updated">
          <day>6</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="revised">
          <day>3</day>
          <month>9</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="hnpp" document-type="chapter">Hereditary Neuropathy with Liability to Pressure Palsies</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="hsan2" document-type="chapter">Hereditary Sensory and Autonomic Neuropathy Type II</related-object>
      <abstract id="paragangliomas.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues symmetrically distributed along the paravertebral axis from the base of the skull to the pelvis) and by pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas hypersecrete catecholamines; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base, neck, and upper medistinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically hypersecrete catecholamines. Symptoms of PGL/PCC result either from mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for malignant transformation is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas or skull base and neck paragangliomas.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of hereditary PGL/PCC syndromes is based on physical examination, family history, imaging studies, biochemical testing, and molecular genetic testing. <italic toggle="yes">SDHA, SDHB, SDHC</italic> and <italic toggle="yes">SDHD</italic> are four nuclear genes that encode the four subunits of the mitochondrial enzyme succinate dehydrogenase (SDH). A fifth nuclear gene, <italic toggle="yes">SDHAF2</italic> (also known as <italic toggle="yes">SDH5</italic>) encodes a protein that appears to be required for flavination of another SDH subunit, SDHA. These are collectively known as the <italic toggle="yes">SDHx</italic> genes. Pathogenic variants in <italic toggle="yes">MAX</italic> predispose to PCC; a subset of individuals with pathogenic variants in <italic toggle="yes">MAX</italic> will also develop PGL. <italic toggle="yes">KIF1B,</italic>
<italic toggle="yes">EGLN1</italic> (formerly known as <italic toggle="yes">PHD2</italic>), <italic toggle="yes">IDH1,</italic> and <italic toggle="yes">FH</italic> have been reported to be associated with hereditary PGL/PCC, but their clinical significance is still unclear.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> For secretory tumors including pheochromocytomas, antagonism of catecholamine excess with pharmacologic adrenergic receptor blockade followed by surgery. For nonsecretory skull base and neck paragangliomas, surgical resection if feasible. PGL/PCCs identified in individuals known to have <italic toggle="yes">SDHB</italic> pathogenic variants require resection promptly because of the high risk for malignant transformation.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Early detection through surveillance and removal of tumors may prevent or minimize complications related to mass effects, catecholamine hypersecretion, and malignant transformation.</p>
          <p><italic toggle="yes">Surveillance:</italic> Beginning at age ten years or at least ten years before the earliest age at diagnosis in the family, individuals at risk for hereditary PGL/PCC syndromes need to begin lifelong biochemical and clinical surveillance for signs and symptoms of PGL/PCC. In individuals who have germline pathogenic variants in genes associated with PGL/PCC, MRI may be the preferable imaging modality to detect new or recurring tumors.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Hypoxia, cigarette smoking.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> First-degree relatives (age &#x02265;10 years) of an individual with a known <italic toggle="yes">SDHA, SDHB, SDHC,</italic>
<italic toggle="yes">SDHD, SDHAF2,</italic> or <italic toggle="yes">MAX</italic> pathogenic variant should be offered molecular genetic testing to clarify their genetic status to improve diagnostic certainty and reduce the need for costly screening procedures in those who have not inherited the pathogenic variant.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>The hereditary PGL/PCC syndromes are inherited in an autosomal dominant manner. Pathogenic variants in <italic toggle="yes">SDHD</italic> (PGL1) demonstrate parent-of-origin effects and generally cause disease only when the pathogenic variant is inherited from the father. Initial data suggest that pathogenic variants in <italic toggle="yes">SDHAF2</italic> (PGL2) and <italic toggle="yes">MAX</italic> exhibit parent-of-origin effects similar to those of pathogenic variants in <italic toggle="yes">SDHD</italic>. A proband with a hereditary PGL/PCC syndrome may have inherited the pathogenic variant from a parent or have a <italic toggle="yes">de novo</italic> pathogenic variant; the proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown. Each child of an individual with a hereditary PGL/PCC syndrome has a 50% chance of inheriting the pathogenic variant. An individual who inherits a <italic toggle="yes">SDHD</italic> pathogenic variant from his/her mother is at a low but not negligible risk of developing disease; each of his/her offspring is at a 50% risk of inheriting the pathogenic variant. An individual who inherits an <italic toggle="yes">SDHD</italic> pathogenic variant from his/her father is at high risk of manifesting paragangliomas and, to a lesser extent, pheochromocytomas. If the pathogenic variant in the family is known, prenatal testing for pregnancies at increased risk is possible through laboratories offering either testing for the gene of interest or custom testing.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="paragangliomas.Diagnosis">
        <title>Diagnosis</title>
        <sec id="paragangliomas.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes should be considered in all individuals with paragangliomas and/or pheochromocytomas, particularly those with the following findings [<xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Tumors that are:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Multiple (i.e., &#x0003e;1 paraganglioma or pheochromocytoma), including bilateral adrenal pheochromocytoma</p>
                </list-item>
                <list-item>
                  <p>Multifocal with multiple synchronous or metachronous tumors</p>
                </list-item>
                <list-item>
                  <p>Recurrent</p>
                </list-item>
                <list-item>
                  <p>Early onset (i.e., age &#x0003c;45 years)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A family history of such tumors</p>
              <p>Note: Many individuals with a hereditary PGL/PCC syndrome may present with a solitary tumor of the skull base or neck, thorax, abdomen, adrenal, or pelvis and no family history of the disorder (i.e., simplex cases: a single known occurrence in a family) [<xref ref-type="bibr" rid="paragangliomas.REF.baysal.2002.178">Baysal et al 2002</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.neumann.2002.1459">Neumann et al 2002</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.badenhop.2004.e99">Badenhop et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.amar.2005.8812">Amar et al 2005</xref>].</p>
            </list-item>
          </list>
          <p>The 2004 World Health Organization (WHO) Classification of Endocrine Tumours [<xref ref-type="bibr" rid="paragangliomas.REF.delellis.2004">DeLellis et al 2004</xref>] classifies paragangliomas/pheochromocytomas by location and, directly or indirectly, secretory status (i.e., sympathetic [which hypersecrete catecholamines] vs parasympathetic [which do not]).</p>
          <p>The following discussion of tumor types is based on the WHO classification of endocrine tumors [<xref ref-type="bibr" rid="paragangliomas.REF.kimura.a">Kimura et al 2004a</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.kimura.b">Kimura et al 2004b</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.lloyd.2004">Lloyd et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.mcnicol.2004">McNicol et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.thompson.2004">Thompson et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.tischler.2004">Tischler &#x00026; Komminoth 2004</xref>].</p>
          <p><bold>Paragangliomas</bold> (paraganglion tumors) arise from neuroendocrine tissues (paraganglia) symmetrically distributed along the paravertebral axis from their predominant location at the base of the skull and neck to the pelvis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Paragangliomas in the skull base, upper mediastinum, and neck are primarily associated with the parasympathetic nervous system and generally do not hypersecrete catecholamines or other hormones. Approximately 5% of skull base and neck paragangliomas hypersecrete catecholamines.</p>
            </list-item>
            <list-item>
              <p>Paragangliomas in the lower mediastinum, abdomen, and pelvis are typically associated with the sympathetic nervous system and usually hypersecrete catecholamines.</p>
            </list-item>
          </list>
          <p>Note: Sympathetic paragangliomas located along the paravertebral axis (and not in the adrenal gland) are called &#x0201c;extra-adrenal sympathetic paragangliomas.&#x0201d;</p>
          <p><bold>Pheochromocytomas</bold> are catecholamine-secreting paragangliomas confined to the adrenal medulla. Pheochromocytomas are also known as adrenal chromaffin tumors.</p>
          <p>Note: &#x0201c;Chromaffin cells/tumors&#x0201d; is another term for any sympathetic (catecholamine-secreting) neuroendocrine cells/tumors regardless of location. Chromaffin refers to the brown-black color that results from oxidization and polymerization of catecholamines contained in the cells/tumors by chromium salts (e.g., potassium dichromate).</p>
          <p><bold>The diagnosis of paragangliomas and pheochromocytomas</bold> is based on <xref ref-type="sec" rid="paragangliomas.Physical_Examination">physical examination</xref>, <xref ref-type="sec" rid="paragangliomas.Imaging_Studies">imaging studies</xref>, and <xref ref-type="sec" rid="paragangliomas.Biochemical_Testing">biochemical testing</xref>. Issues related to diagnosis (among other topics) are addressed in recently published clinical practice guidelines [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-1498">full text</ext-link>; registration or institutional access required).</p>
          <sec id="paragangliomas.Physical_Examination">
            <title>Physical Examination</title>
            <p><bold>Patient evaluation</bold> includes the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Detailed family history, including specific knowledge of any relatives with unexplained or incompletely explained sudden death</p>
              </list-item>
              <list-item>
                <p>Personal medical history for the following:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Symptoms of catecholamine excess that can include sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, palpitations (perceived episodic, forceful, often rapid heartbeat), pallor, and apprehension or anxiety</p>
                  </list-item>
                  <list-item>
                    <p>Paroxysmal symptoms that may be triggered by changes in body position, increases in intra-abdominal pressure, medications (e.g., metoclopramide), anesthesia induction, exercise, or micturition in the case of urinary bladder paragangliomas. Urinary bladder paragangliomas may also be accompanied by painless hematuria.</p>
                  </list-item>
                  <list-item>
                    <p>Evidence of skull base and neck paragangliomas. These tumors may present as enlarging masses that are asymptomatic or associated with symptoms of mass effects from the size and/or location of the tumors. Associated symptoms may include unilateral hearing loss, pulsatile tinnitus, cough, hoarseness of voice, pharyngeal fullness, swallowing difficulty, pain, and/or problems with tongue motion.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Physical examination directed toward signs suggestive of PGL/PCC:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>For sympathetic paragangliomas and pheochromocytomas, signs may include documentation of elevated blood pressure, tachyarrhythmias or other arrhythmias, and palpable abdominal masses.</p>
                  </list-item>
                  <list-item>
                    <p>For skull base and neck paragangliomas, signs may include skull base and neck masses:</p>
                    <list list-type="bullet">
                      <list-item>
                        <p>A carotid body tumor is likely to be vertically adherent and may be associated with bruits or palpable thrills.</p>
                        <p>Note: The carotid bodies are located at or near the bifurcations of the carotid arteries, in the lateral upper neck at approximately the level of the fourth cervical vertebra.</p>
                      </list-item>
                      <list-item>
                        <p>A jugulotympanic tumor may be visible as a blue-colored pulsating mass behind the intact tympanic membrane [<xref ref-type="bibr" rid="paragangliomas.REF.gujrathi.2005.339">Gujrathi &#x00026; Donald 2005</xref>].</p>
                      </list-item>
                    </list>
                  </list-item>
                </list>
              </list-item>
            </list>
          </sec>
          <sec id="paragangliomas.Imaging_Studies">
            <title>Imaging Studies</title>
            <p><bold>For diagnosis and tumor localization</bold>, the following studies can be used [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2005.665">Lenders et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2006.21">Young 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2007.601">Young 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>CT/MRI.</bold> It has been suggested that CT rather than MRI be the imaging modality of choice, given its excellent spatial resolution of the thorax, abdomen, and pelvis [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>]. MRI is a better option in affected individuals with metastatic disease, or when radiation exposure must be limited (e.g., pregnant women and those with known germline pathogenic variants).</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Paragangliomas may be identified anywhere along the paravertebral axis from the skull base to the pelvis, including the paraortic sympathetic chain. Common sites of neoplasia are near the renal vessels and in the organ of Zuckerkandl (chromaffin tissues near the origin of the inferior mesenteric artery and the aortic bifurcation). A less common site is within the urinary bladder wall.</p>
                  </list-item>
                  <list-item>
                    <p>PGL/PCC tumors usually exhibit high signal intensity on T<sub>2</sub>-weighted MRI, which helps distinguish pheochromocytomas from benign adrenal cortical adenomas. On CT these tumors are characterized by heterogeneous appearance with cystic areas, high unenhanced CT attenuation (density), increased vascularity on contrast-enhanced CT, and slow contrast washout.</p>
                  </list-item>
                  <list-item>
                    <p>Multiple tumors can be present.</p>
                  </list-item>
                  <list-item>
                    <p>The diagnostic sensitivities and specificities of CT and MRI are equivalent: approximately 90%-100% and 70%-80%, respectively.</p>
                  </list-item>
                  <list-item>
                    <p>Whole-body short tau inversion recovery (STIR) MRI with targeted MRI for positive tumors may be a reasonable approach for both diagnosis and monitoring. This strategy minimizes radiation exposure associated with CT scanning, while taking advantage of the high sensitivity of T<sub>2-</sub>weighted MRI.</p>
                  </list-item>
                </list>
                <p>Note: MRI and CT are also used for tumor staging [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2005.665">Lenders et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2006.21">Young 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Sonography.</bold> B-mode sonography coupled with color-coded Doppler sonography is useful for diagnosis of carotid body and vagal paragangliomas.</p>
              </list-item>
              <list-item>
                <p>Digital subtraction angiography (DSA)</p>
                <list list-type="bullet">
                  <list-item>
                    <p>DSA is sensitive for the detection of small paragangliomas and can be diagnostically definitive.</p>
                  </list-item>
                  <list-item>
                    <p>DSA is essential if preoperative embolization or carotid artery occlusion is to be performed.</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <p><bold>To detect metastases,</bold> the following studies can be used [<xref ref-type="bibr" rid="paragangliomas.REF.gujrathi.2005.339">Gujrathi &#x00026; Donald 2005</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p><bold><sup>123</sup>I-metaiodobenzylguanidine (MIBG) scintigraphy</bold> is a technique that measures tumor uptake of a catecholamine analog radioisotope:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>MIBG has greater specificity for localization than CT and MRI, but lower sensitivity.</p>
                  </list-item>
                  <list-item>
                    <p>It may be used to:</p>
                    <list list-type="bullet">
                      <list-item>
                        <p>Further characterize masses detected by CT or MRI;</p>
                      </list-item>
                      <list-item>
                        <p>Look for additional sites of disease;</p>
                      </list-item>
                      <list-item>
                        <p>Identify tumors when CT or MRI results are negative [<xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>].</p>
                      </list-item>
                    </list>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Octreotide scintigraphy</bold>, a technique that measures tumor uptake of a somatostatin analog radioisotope, may be used in addition to MIBG scintigraphy as some MIBG-negative tumors are positive with octreotide scintigraphy.</p>
              </list-item>
              <list-item>
                <p><bold>2-<sup>18</sup>F-fluoro-2-deoxy-D-glucose position emission tomography (FDG-PET)</bold>, or PET using other imaging compounds, can also assist in detecting metastatic disease.</p>
              </list-item>
            </list>
            <p>A decisional algorithm for the use of functional imaging in PGL/PCC has recently been proposed in the Endocrine Society&#x02019;s Clinical Practice Guideline (Figure 2) [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-1498">full text</ext-link>; registration or institutional access required).</p>
          </sec>
        </sec>
        <sec id="paragangliomas.Testing">
          <title>Testing</title>
          <sec id="paragangliomas.Biochemical_Testing">
            <title>Biochemical Testing</title>
            <p>Catecholamines and metanephrines hypersecreted by PGL/PCC can be any of the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Epinephrine (adrenaline) and its major metabolite metanephrine</p>
              </list-item>
              <list-item>
                <p>Norepinephrine (noradrenaline) and its major metabolite normetanephrine</p>
              </list-item>
              <list-item>
                <p>Dopamine and its major metabolite methyoxytyramine</p>
              </list-item>
            </list>
            <p>When a catecholamine-secreting tumor is suspected, plasma and/or 24-hour urinary fractionated metanephrines and catecholamines are evaluated for catecholamine hypersecretion.</p>
            <p>Note: (1) Measurement of fractionated metanephrine concentrations in plasma or urine is preferred, as it is more sensitive than measurement of catecholamine concentrations [<xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>]. (2) False positive results may be reduced by follow-up testing for 24-hour urine fractionated metanephrines when plasma normetanephrine concentrations are less than fourfold above the reference range [<xref ref-type="bibr" rid="paragangliomas.REF.algecirasschimnich.2008.91">Algeciras-Schimnich et al 2008</xref>]. (3) The secretion of epinephrine with little norepinephrine excess suggests an adrenal pheochromocytoma, which may be associated with <related-object link-type="booklink" source-id="gene" document-id="men2" document-type="chapter">multiple endocrine neoplasia type 2</related-object> [<xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>].</p>
            <p><bold>Biopsy.</bold> Biopsy of skull base and neck paragangliomas is not normally required and may be contraindicated because this invasive procedure carries the risk of precipitating a hypertensive crisis, hemorrhage, and tumor cell seeding. In addition, biopsy of adrenal pheochromocytoma or abdominal paraganglioma should be avoided [<xref ref-type="bibr" rid="paragangliomas.REF.vanderveen.2009.1158">Vanderveen et al 2009</xref>].</p>
            <p><bold>Tumor immunohistochemistry.</bold> When any component of the mitochondrial complex 2 is completely inactivated, it appears that the entire complex becomes unstable, resulting in degradation of the SDHB subunit. Therefore, immunohistochemistry for SDHB is negative whenever there is complete inactivation of <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC</italic>, <italic toggle="yes">SDHD,</italic> or <italic toggle="yes">SDHAF2</italic>. As a result, negative immunohistochemical staining for SDHB seems to occur whenever there is germline mutation of <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC,</italic> or <italic toggle="yes">SDHD</italic> accompanied by inactivation of the normal allele; thus, negative staining for SDHB would appear to be a promising marker suggestive of a germline pathogenic variant of any of the SDH subunits [<xref ref-type="bibr" rid="paragangliomas.REF.gill.2010.805">Gill et al 2010</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pai.2014.1130">Pai et al 2014</xref>]. Germline pathogenic variants in <italic toggle="yes">SDHA</italic> show loss of staining for SDHA, in addition to loss of staining for SDHB [<xref ref-type="bibr" rid="paragangliomas.REF.korpershoek.2011.e1472">Korpershoek et al 2011</xref>]. It is being proposed that SDHB immunohistochemistry be used in both familial and apparently sporadic PGL/PCC cases to guide molecular genetic testing; however, evidence is currently insufficient to advocate for the routine use of immunohistochemistry to guide molecular testing.</p>
            <p>Since there are still some challenges in interpreting SDHB immunohistochemistry, and the procedure is not widely available, it is unclear whether it should be routinely performed.</p>
          </sec>
          <sec id="paragangliomas.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> The genes in which pathogenic variants are known to cause individual hereditary PGL/PCC syndromes:</p>
            <list list-type="bullet">
              <list-item>
                <p>PGL1. <italic toggle="yes">SDHD</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.baysal.2000.848">Baysal et al 2000</xref>]</p>
              </list-item>
              <list-item>
                <p>PGL2. <italic toggle="yes">SDHAF2</italic> (sometimes referred to as <italic toggle="yes">SDH5)</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.hao.2009.1139">Hao et al 2009</xref>]</p>
              </list-item>
              <list-item>
                <p>PGL3. <italic toggle="yes">SDHC</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.niemann.2000.268">Niemann &#x00026; Muller 2000</xref>]</p>
              </list-item>
              <list-item>
                <p>PGL4. <italic toggle="yes">SDHB</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.astuti.2001.49">Astuti et al 2001</xref>]</p>
              </list-item>
              <list-item>
                <p>PGL5. <italic toggle="yes">SDHA</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2010.3011">Burnichon et al 2010</xref>]</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">MAX</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.cominom_ndez.2011.663">Comino-M&#x000e9;ndez et al 2011</xref>]</p>
              </list-item>
            </list>
            <p><bold>Genes possibly associated with PGL/PCC syndromes.</bold>
<italic toggle="yes">KIF1B</italic>, <italic toggle="yes">EGLN1</italic> (formerly known as <italic toggle="yes">PHD2</italic>), <italic toggle="yes">IDH1</italic>, and <italic toggle="yes">FH</italic> have been reported to be associated with hereditary PGL/PCC; their clinical significance is as yet unclear (see <xref ref-type="sec" rid="paragangliomas.Resources">Molecular Genetics</xref>).</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sequence analysis.</bold> Sequence analysis of the coding regions of <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC</italic>, and <italic toggle="yes">SDHD,</italic> and associated intron-exon junctions detects approximately 70% of familial cases of skull base and neck paraganglioma [<xref ref-type="bibr" rid="paragangliomas.REF.baysal.2002.178">Baysal et al 2002</xref>]. Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="paragangliomas-mutations.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for a summary of reports of pathogenic variants in these genes in different populations.</p>
              </list-item>
            </list>
            <table-wrap id="paragangliomas.T.summary_of_molecular_ge" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Hereditary Paraganglioma-Pheochromocytoma Syndromes</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup><break/>(Locus)</th>
                    <th id="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of Hereditary PGL/PCC Attributed to Pathogenic Variants in This Gene</th>
                    <th id="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">SDHD</italic><break/>(PGL1)</td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">~30%&#x000a0;<sup>2</sup><break/>~40%-50% of skull base and neck PGL&#x000a0;<sup>3</sup><break/>~15% of chest, abdomen, pelvic PGL/PCC&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5,&#x000a0;6,&#x000a0;7,&#x000a0;8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>9,&#x000a0;10</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">SDHB</italic>
<break/>(PGL4)</td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">22%-38%&#x000a0;<sup>2</sup><break/>12%-20% of skull base and neck PGL&#x000a0;<sup>3</sup><break/>24%-44% of chest, abdomen, pelvic PGL/PCC&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5,&#x000a0;11,&#x000a0;12</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>9,&#x000a0;10</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">SDHC</italic>
<break/>(PGL3)</td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">4-8%&#x000a0;<sup>2,&#x000a0;13</sup></td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5,&#x000a0;11</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>9,&#x000a0;10</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">SDHA</italic><break/>(PGL5)</td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0.6-3%&#x000a0;<sup>2,&#x000a0;14</sup></td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">SDHAF2</italic>
<break/>(PGL2)</td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">Unknown</td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5,&#x000a0;11,&#x000a0;15</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Sequence analysis of select exons&#x000a0;<sup>6,&#x000a0;16</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Targeted analysis for c.232G&#x0003e;A&#x000a0;<sup>17</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MAX</italic>
                    </td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown</td>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.summary_of_molecular_ge_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>9,&#x000a0;18</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="paragangliomas.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="paragangliomas.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="paragangliomas.TF.1.2">
                  <label>2. </label>
                  <p><xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2009.2817">Burnichon et al [2009]</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.buffet.2012.359">Buffet et al [2012]</xref></p>
                </fn>
                <fn id="paragangliomas.TF.1.3">
                  <label>3. </label>
                  <p>Pedigrees with familial/syndromic presentations of skull base and neck PGL [<xref ref-type="bibr" rid="paragangliomas.REF.baysal.2002.178">Baysal et al 2002</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2009.2817">Burnichon et al 2009</xref>]</p>
                </fn>
                <fn id="paragangliomas.TF.1.4">
                  <label>4. </label>
                  <p>Pedigrees with inherited and extra-adrenal sympathetic PGL and PCC [<xref ref-type="bibr" rid="paragangliomas.REF.amar.2005.8812">Amar et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2009.2817">Burnichon et al 2009</xref>]</p>
                </fn>
                <fn id="paragangliomas.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="paragangliomas.TF.1.6">
                  <label>6. </label>
                  <p>Exons may vary by laboratory.</p>
                </fn>
                <fn id="paragangliomas.TF.1.7">
                  <label>7. </label>
                  <p>Three <italic toggle="yes">SDHD</italic> pathogenic variants (<xref ref-type="table" rid="paragangliomas.T.selected_sdhd_pathogeni">p.Asp92Tyr</xref>, <xref ref-type="table" rid="paragangliomas.T.selected_sdhd_pathogeni">p.Leu95Pro</xref>, <xref ref-type="table" rid="paragangliomas.T.selected_sdhd_pathogeni">p.Leu139Pro</xref>) are responsible for almost all cases of hereditary paraganglioma in the Dutch population [<xref ref-type="bibr" rid="paragangliomas.REF.taschner.2001.274">Taschner et al 2001</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.dannenberg.2002.2061">Dannenberg et al 2002</xref>]. The pathogenic variants p.Asp92Tyr and p.Leu139Pro were identified in 30 of 32 Dutch families with familial skull base and neck paragangliomas (94%) and 20/55 (36%) of simplex cases [<xref ref-type="bibr" rid="paragangliomas.REF.taschner.2001.274">Taschner et al 2001</xref>]. It has been proposed that the <italic toggle="yes">SDHD</italic> pathogenic variant <xref ref-type="table" rid="paragangliomas.T.selected_sdhd_pathogeni">p.Met1Ile</xref> is a founder variant in the Chinese population [<xref ref-type="bibr" rid="paragangliomas.REF.lee.2003.1055">Lee et al 2003</xref>].</p>
                </fn>
                <fn id="paragangliomas.TF.1.8">
                  <label>8. </label>
                  <p>In the Netherlands, 94% of inherited skull base and neck PGL is caused by two <italic toggle="yes">SDHD</italic> founder variants: <xref ref-type="table" rid="paragangliomas.T.selected_sdhd_pathogeni">p.Asp92Tyr</xref> and <xref ref-type="table" rid="paragangliomas.T.selected_sdhd_pathogeni">p.Leu139Pro</xref> [<xref ref-type="bibr" rid="paragangliomas.REF.taschner.2001.274">Taschner et al 2001</xref>].</p>
                </fn>
                <fn id="paragangliomas.TF.1.9">
                  <label>9. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="paragangliomas.TF.1.10">
                  <label>10. </label>
                  <p>One study found gross deletions in <italic toggle="yes">SDHB</italic> in 12% of individuals in whom sequence analysis failed to identify a pathogenic variant [<xref ref-type="bibr" rid="paragangliomas.REF.casc_n.2006.213">Casc&#x000f3;n et al 2006</xref>]. In one study from a large French registry, 9.1% of individuals had a large deletion in <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC</italic>, or <italic toggle="yes">SDHD</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2009.2817">Burnichon et al 2009</xref>]. In the decade-long French study, the frequency of large deletions was 13.1% of all pathogenic variants in <italic toggle="yes">SDHB</italic>, 5% in <italic toggle="yes">SDHD</italic>, and 16.7% in <italic toggle="yes">SDHC</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.buffet.2012.359">Buffet et al 2012</xref>].</p>
                </fn>
                <fn id="paragangliomas.TF.1.11">
                  <label>11. </label>
                  <p>Sequence analysis and scanning of the entire gene can have similar variant detection frequencies; however, pathogenic variant detection rates for variant scanning may vary considerably among laboratories depending on the specific protocol used.</p>
                </fn>
                <fn id="paragangliomas.TF.1.12">
                  <label>12. </label>
                  <p>A whole-exon deletion of <italic toggle="yes">SDHB</italic> exon 1 appears to be a founder variant in the Spanish population [<xref ref-type="bibr" rid="paragangliomas.REF.casc_n.2008.233">Casc&#x000f3;n et al 2008</xref>].</p>
                </fn>
                <fn id="paragangliomas.TF.1.13">
                  <label>13. </label>
                  <p>Five of 121 individuals included in a European skuli base and neck paraganglioma registry were found to have <italic toggle="yes">SDHC</italic> pathogenic variants [<xref ref-type="bibr" rid="paragangliomas.REF.schiavi.2005.2057">Schiavi et al 2005</xref>].</p>
                </fn>
                <fn id="paragangliomas.TF.1.14">
                  <label>14. </label>
                  <p>
                    <xref ref-type="bibr" rid="paragangliomas.REF.korpershoek.2011.e1472">Korpershoek et al [2011]</xref>
                  </p>
                </fn>
                <fn id="paragangliomas.TF.1.15">
                  <label>15. </label>
                  <p>
                    <xref ref-type="bibr" rid="paragangliomas.REF.hao.2009.1139">Hao et al [2009]</xref>
                  </p>
                </fn>
                <fn id="paragangliomas.TF.1.16">
                  <label>16. </label>
                  <p>Sequence variants of exon 2</p>
                </fn>
                <fn id="paragangliomas.TF.1.17">
                  <label>17. </label>
                  <p>Three individuals with hereditary PGL/PCC from the Dutch family described by <xref ref-type="bibr" rid="paragangliomas.REF.van_baars.1982.305">van Baars et al [1982]</xref> were identified as having a single-nucleotide change (<xref ref-type="table" rid="paragangliomas.T.selected_sdhaf2_pathoge">c.232G&#x0003e;A</xref>) in exon 2 of <italic toggle="yes">SDHAF2</italic> (also known as <italic toggle="yes">SDH5)</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.hao.2009.1139">Hao et al 2009</xref>].</p>
                </fn>
                <fn id="paragangliomas.TF.1.18">
                  <label>18. </label>
                  <p>
                    <xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2012.2828">Burnichon et al [2012]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="paragangliomas.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> The Endocrine Society has recently published guidelines suggesting a diagnostic approach for individuals with suspected hereditary PCC/PGL [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>]. It should be borne in mind, however, that with rapidly evolving sequencing technology, these guidelines may change.</p>
          <p>The strategy employed should use all available clinical data (family history, physical exam, tumor location, presence of metastases, and biochemical phenotype) to make the best clinical judgment with regard to the most likely genetic etiology in each affected individual or family. The decision can then be made for pursuing genetic testing in a step-wise fashion, and multiple algorithms have been suggested using this approach [<xref ref-type="bibr" rid="paragangliomas.REF.erlic.2009.6378">Erlic et al 2009</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.neumann.2009.3650">Neumann et al 2009</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.welander.2011.r253">Welander et al 2011</xref>]. A novel approach is to use multi-gene testing panels, which may save time, although there is no clear consensus on which approach is the best.</p>
          <p><bold>One genetic testing strategy</bold> is to prioritize genetic testing based on clinical features. Features such as young age at onset, presence of bilateral, extra-adrenal or multiple tumors, or malignancy suggest an inherited disorder [<xref ref-type="bibr" rid="paragangliomas.REF.gimenezroqueplo.2006.699">Gimenez-Roqueplo et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>]. See <xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al [2014]</xref> guidelines, Figure 1 for a genetic testing algorithm based on the clinical features of the tumor(s) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-1498">full text</ext-link>; registration or institutional access required). The roles of <italic toggle="yes">KIF1B, EGLN1, IDH1</italic>, and <italic toggle="yes">FH</italic> in disease pathogenesis are unclear and need not be considered in routine clinical testing.</p>
          <p>Note: The absence of family history or other features suggestive of a hereditary syndrome should not preclude genetic testing.</p>
          <list list-type="bullet">
            <list-item>
              <p>Persons with nonsecretory (parasympathetic) or secretory (sympathetic) skull base and neck paragangliomas should initially be tested for pathogenic variants in <italic toggle="yes">SDHD</italic>, followed by <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC,</italic> and finally <italic toggle="yes">SDHAF2</italic>.</p>
            </list-item>
            <list-item>
              <p>Because of the relatively low age-related penetrance, the tendency of chromaffin tumors to undergo malignant transformation, and the adverse prognosis associated with malignant paragangliomas and pheochromocytomas [<xref ref-type="bibr" rid="paragangliomas.REF.amar.2007.3822">Amar et al 2007</xref>], testing for <italic toggle="yes">SDHB</italic> pathogenic variants should be considered for all simplex cases, particularly those with extra-adrenal tumors.</p>
            </list-item>
            <list-item>
              <p>Persons with extra-adrenal sympathetic paragangliomas should initially be tested for pathogenic variants in <italic toggle="yes">SDHB,</italic> followed by <italic toggle="yes">SDHD</italic>, <italic toggle="yes">VHL</italic> (see <xref ref-type="sec" rid="paragangliomas.Differential_Diagnosis">Differential Diagnosis</xref>), and then <italic toggle="yes">SDHC</italic>.</p>
              <p>Note: A substantial proportion of individuals with an <italic toggle="yes">SDHB</italic> pathogenic variant present as simplex cases [<xref ref-type="bibr" rid="paragangliomas.REF.amar.2005.8812">Amar et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.timmers.2007.779">Timmers et al 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.klein.2008.94">Klein et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Persons with pheochromocytomas without evidence for <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis type I</related-object>, <related-object link-type="booklink" source-id="gene" document-id="vhl" document-type="chapter">von Hippel-Lindau disease</related-object> (caused by mutation of <italic toggle="yes">VHL</italic>), or <related-object link-type="booklink" source-id="gene" document-id="men2" document-type="chapter">multiple endocrine neoplasia type 2</related-object> (MEN2, caused by mutation of <italic toggle="yes">RET</italic>) should be evaluated for <italic toggle="yes">SDHB</italic> and <italic toggle="yes">SDHD</italic> pathogenic variants, followed by <italic toggle="yes">TMEM127</italic> and <italic toggle="yes">MAX</italic> (see <xref ref-type="sec" rid="paragangliomas.Differential_Diagnosis">Differential Diagnosis</xref>):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Individuals with <italic toggle="yes">VHL-</italic> and <italic toggle="yes">RET</italic>-related disease especially tend to present at younger ages.</p>
                </list-item>
                <list-item>
                  <p>Bilateral pheochromocytoma is particularly associated with von Hippel-Lindau disease and MEN2 [<xref ref-type="bibr" rid="paragangliomas.REF.gimenezroqueplo.2006.699">Gimenez-Roqueplo et al 2006</xref>].</p>
                </list-item>
                <list-item>
                  <p>The First International Symposium on Pheochromocytoma identified early age of onset as an important consideration in the decision to test for pathogenic variants in disease-related genes, and has endorsed a stepwise approach to genetic testing, which includes the type of catecholamine produced by the tumor [<xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>].</p>
                </list-item>
                <list-item>
                  <p>Pheochromocytomas in individuals with von Hippel-Lindau appear to universally produce norepinephrine and normetanephrine, whereas those in individuals with MEN2 always produce epinephrine and metanephrine [<xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>An individual with a malignant tumor should initially be tested for pathogenic variants in <italic toggle="yes">SDHB</italic>.</p>
            </list-item>
          </list>
          <table-wrap id="paragangliomas.T.distinguishing_clinical" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Distinguishing Clinical Features of PGL/PCC by Genetic Etiology</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1">Mutated Gene</th>
                  <th id="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2" valign="middle" colspan="5" align="left" scope="colgroup" rowspan="1">Distinguishing Clinical Features&#x000a0;<sup>1</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2" id="hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">PGL vs PCC</th>
                  <th headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2" id="hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Bilateral PCC or Multiple PGL</th>
                  <th headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2" id="hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Biochemical Phenotype</th>
                  <th headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2" id="hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Malignancy Risk</th>
                  <th headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2" id="hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Transmission</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">RET</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PCC</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~60% bilateral</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Epinephrine</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">VHL</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PCC</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~40% bilateral</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Norepinephrine</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">NF1</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PCC</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~15% bilateral</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Epinephrine</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">~9%</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SDHD</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PGL (skull base &#x00026; neck)</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~50% multiple</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Norepinephrine / dopamine</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Paternal&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SDHB</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PGL</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~20% multiple</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Norepinephrine / dopamine</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">34%-97%</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SDHC</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PGL</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~20% multiple</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Norepinephrine / dopamine</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Low</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SDHAF2</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PGL (skull base &#x00026; neck)</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~90% multiple</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Unclear</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Low</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Paternal</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SDHA</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PGL</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Single</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Low</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">TMEM127</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PCC</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~40% bilateral</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c; 5%</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MAX</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">PCC</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~60% bilateral</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Mixed</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">25%</td>
                  <td headers="hd_h_paragangliomas.T.distinguishing_clinical_1_1_1_2 hd_h_paragangliomas.T.distinguishing_clinical_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Paternal</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>AD = autosomal dominant</p>
              </fn>
              <fn id="paragangliomas.TF.2.1">
                <label>1. </label>
                <p>General rules of thumb; exceptions exist.</p>
              </fn>
              <fn id="paragangliomas.TF.2.2">
                <label>2. </label>
                <p>One case of maternal transmission has been reported.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">SDHD</italic>, <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC</italic>, <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHAF2</italic>, <italic toggle="yes">MAX</italic>, and other genes of interest (see <xref ref-type="sec" rid="paragangliomas.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <p><bold>Genomic testing.</bold> If single gene testing (and/or use of a multi-gene panel) has not confirmed a diagnosis in an individual with features of PGL/PCC, genomic testing may be considered. Such testing may include exome sequencing, genome sequencing, and mitochondrial sequencing. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
        </sec>
      </sec>
      <sec id="paragangliomas.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="paragangliomas.Clinical_Description">
          <title>Clinical Description</title>
          <p>In the hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes, tumors arise within the paraganglia, collections of neural crest cells symmetrically distributed along the paravertebral axis from the base of the skull to the pelvis.</p>
          <p><bold>Paraganglia in the skull base and neck</bold> are generally associated with the parasympathetic nervous system, with the largest tissue collections located in the areas surrounding the carotid body, vagus nerve, and jugulotympanic region. Paragangliomas in these sites typically do not hypersecrete catecholamines. Most skull base and neck paragangliomas do not metastasize; their untoward consequences are typically the result of mass effects:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Carotid body paragangliomas</bold> classically present as asymptomatic, enlarging lateral neck masses. Affected individuals may experience mass effects, including cranial nerve and sympathetic chain compression, with resulting neuropathies. On physical examination masses are vertically (but not horizontally) fixed; bruits and/or thrills may be present.</p>
            </list-item>
            <list-item>
              <p><bold>Vagal paragangliomas</bold> present in a manner similar to carotid body paragangliomas. Signs and symptoms include neck masses, hoarseness, pharyngeal fullness, dysphagia, dysphonia (impaired use of the voice), pain, cough, and aspiration. Dysphonia may be caused by mass effects within the throat or by pressure on nerves supplying the vocal cords or tongue.</p>
            </list-item>
            <list-item>
              <p><bold>Jugulotympanic paragangliomas</bold> may present with pulsatile tinnitus, hearing loss, and other lower cranial nerve abnormalities. Blue-colored, pulsatile masses may be visualized behind the tympanic membrane on otoscopic examination [<xref ref-type="bibr" rid="paragangliomas.REF.gujrathi.2005.339">Gujrathi &#x00026; Donald 2005</xref>].</p>
            </list-item>
          </list>
          <p><bold>Paraganglia in the thorax, abdomen, and pelvis</bold> are normally associated with the sympathetic nervous system, and tumors of these paraganglioma may hypersecrete catecholamines. The adrenal medulla has the largest collection of sympathetic paraganglion cells.</p>
          <p><bold>Pheochromocytomas and extra-adrenal sympathetic paragangliomas</bold> in PGL/PCC syndromes present in a manner similar to those in persons with sporadic (i.e., not inherited) tumors, most often coming to medical attention in the following four clinical settings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Signs and symptoms associated with catecholamine hypersecretion, including elevations in blood pressure and pulse, headaches, forceful palpitations, excessive sweating, and anxiety. Nausea, emesis, fatigue, and weight loss can also be seen. Symptoms are often episodic [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2005.665">Lenders et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2006.21">Young 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Signs and symptoms related to mass effects from the neoplasm</p>
            </list-item>
            <list-item>
              <p>Incidentally discovered mass on MRI/CT performed for other reasons</p>
            </list-item>
            <list-item>
              <p>Screening of at-risk relatives [<xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>]</p>
            </list-item>
          </list>
          <p>Extra-adrenal sympathetic paragangliomas have an increased likelihood of malignant transformation [<xref ref-type="bibr" rid="paragangliomas.REF.proye.1992.651">Proye et al 1992</xref>]. Malignancy is much less likely in pheochromocytomas but does occur (see <xref ref-type="sec" rid="paragangliomas.GenotypePhenotype_Correla">Genotype-Phenotype Correlations</xref>).</p>
          <p><bold>Manifestations of PGL/PCCs.</bold> Compared to persons with sporadic tumors, individuals with germline pathogenic variants in <italic toggle="yes">SDHx</italic> genes tend to present at younger ages and to be more likely to have multifocal, bilateral, and recurrent disease, or to have multiple synchronous neoplasms.</p>
          <p>Because <italic toggle="yes">SDHC</italic> pathogenic variants are rare, data on phenotypic characteristics associated with <italic toggle="yes">SDHC</italic> pathogenic variants are limited. In a review of 22 individuals with <italic toggle="yes">SDHC</italic> pathogenic variants who had skull base and neck paragangliomas (15 from the literature, 7 from an internally evaluated series), <xref ref-type="bibr" rid="paragangliomas.REF.schiavi.2005.2057">Schiavi et al [2005]</xref> found no clinical, pathologic, or demographic features that clearly differentiated persons with <italic toggle="yes">SDHC</italic> pathogenic variants from 88 index cases and two simplex cases from the literature with skull base and neck paragangliomas in whom pathogenic variants in <italic toggle="yes">SDHD</italic>, <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC</italic>, <italic toggle="yes">VHL</italic>, and <italic toggle="yes">RET</italic> were not detected.</p>
          <p>Benign PGL/PCCs are generally slow growing &#x02014; approximately 0.5 to 1.0 cm increase in diameter per year [<xref ref-type="bibr" rid="paragangliomas.REF.young.2007.601">Young 2007</xref>]. By contrast, malignant tumors are typically more aggressive, although malignant tumors with indolent courses have been documented [<xref ref-type="bibr" rid="paragangliomas.REF.young.2002.4101">Young et al 2002</xref>].</p>
          <p>No reliable pathology studies are available to distinguish a primary benign PGL/PCC from a primary malignant PGL/PCC. Consequently, establishing the malignant nature of a tumor relies on the presence of metastases to non-chromaffin sites, the most common of which are bone, lung, liver, and lymph nodes. Having to wait for evidence of metastasis to establish the malignant nature of a tumor may have introduced bias into the present understanding of the natural history of these tumors.</p>
          <p>For PGL/PCCs that have not metastasized, operative treatment can be curative. However, once metastases have occurred the disease is uniformly fatal, with only 50% of affected individuals surviving beyond five years [<xref ref-type="bibr" rid="paragangliomas.REF.thompson.2004">Thompson et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>].</p>
          <p>
            <bold>Other tumors</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Gastrointestinal stromal tumors</bold> may occur in individuals with hereditary PGL/PCC syndromes caused by pathogenic variants in any one of the four genes encoding the SDH subunits [<xref ref-type="bibr" rid="paragangliomas.REF.pasini.2008.79">Pasini et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Renal clear cell carcinoma</bold> and <bold>papillary thyroid carcinoma</bold> have been reported with pathogenic variants in <italic toggle="yes">SDHB</italic> and <italic toggle="yes">SDHD</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.neumann.2002.1459">Neumann et al 2002</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.vanharanta.2004.153">Vanharanta et al 2004</xref>]. However, the significance of these findings is unclear.</p>
            </list-item>
          </list>
          <p><bold>Longevity.</bold> With staged tumor targeted treatment modalities some affected individuals have lived with their disease for 20 or more years [<xref ref-type="bibr" rid="paragangliomas.REF.young.2002.4101">Young et al 2002</xref>].</p>
        </sec>
        <sec id="paragangliomas.GenotypePhenotype_Correla">
          <title>Genotype-Phenotype Correlations</title>
          <p>Although persons with <italic toggle="yes">SDHA, SDHB, SDHC,</italic>
<italic toggle="yes">SDHD,</italic> and <italic toggle="yes">SDHAF2</italic>, and <italic toggle="yes">MAX</italic> pathogenic variants can develop pheochromocytomas and/or paragangliomas within any paraganglion tissue, the following correlations between the gene involved and tumor location are used to guide diagnostic testing and, in some instances, patient care:</p>
          <p>Germline pathogenic variants in <italic toggle="yes">SDHB</italic> are generally associated with higher morbidity and mortality than pathogenic variants in the other <italic toggle="yes">SDHx</italic> genes [<xref ref-type="bibr" rid="paragangliomas.REF.gimenezroqueplo.2003.5615">Gimenez-Roqueplo et al 2003</xref>]. They are strongly associated with extra-adrenal sympathetic paragangliomas [<xref ref-type="bibr" rid="paragangliomas.REF.gimenezroqueplo.2003.5615">Gimenez-Roqueplo et al 2003</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2006.21">Young 2006</xref>] with a high risk of malignancy, and, less frequently, with benign or malignant PCCs and parasympathetic PGLs. Chromaffin tumors in persons with germline <italic toggle="yes">SDHB</italic> pathogenic variants are sixfold more likely to be extra-adrenal than chromaffin tumors in general [<xref ref-type="bibr" rid="paragangliomas.REF.van_nederveen.2006.177">Van Nederveen et al 2006</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Pathogenic variants in <italic toggle="yes">SDHD</italic> and <italic toggle="yes">SDHC</italic> are more frequently associated with parasympathetic skull base and neck paragangliomas than other tumor types [<xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Persons with a germline <italic toggle="yes">SDHD</italic> pathogenic variant have an odds ratio of approximately 24 of developing a skull base and neck paraganglioma compared with persons with a germline <italic toggle="yes">SDHB</italic> pathogenic variant [<xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al 2006</xref>].</p>
                </list-item>
                <list-item>
                  <p>Persons with a germline <italic toggle="yes">SDHD</italic> pathogenic variant have an odds ratio of 0.28 of developing abdominal paragangliomas compared with persons with a germline <italic toggle="yes">SDHB</italic> pathogenic variant [<xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al 2006</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Paragangliomas in persons with a germline <italic toggle="yes">SDHB</italic> pathogenic variant are more likely to become malignant than sporadic paragangliomas or those that develop in persons with germline <italic toggle="yes">SDHD</italic> and <italic toggle="yes">SDHC</italic> pathogenic variants. <italic toggle="yes">SDHB</italic> pathogenic variants may also predict a shorter survival in persons with malignant pheochromocytomas and paragangliomas [<xref ref-type="bibr" rid="paragangliomas.REF.amar.2007.3822">Amar et al 2007</xref>]. Persons with a germline <italic toggle="yes">SDHB</italic> pathogenic variant can develop malignant disease at any paraganglion site [<xref ref-type="bibr" rid="paragangliomas.REF.young.2002.4101">Young et al 2002</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.gimenezroqueplo.2003.5615">Gimenez-Roqueplo et al 2003</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.jim_nez.2006.2851">Jim&#x000e9;nez et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Up to 50% of persons with malignant extra-adrenal paragangliomas have a germline <italic toggle="yes">SDHB</italic> pathogenic variant [<xref ref-type="bibr" rid="paragangliomas.REF.brouwers.2006.4505">Brouwers et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.klein.2008.94">Klein et al 2008</xref>]. Because extra-adrenal sympathetic paragangliomas have long been known to have a greater predisposition to malignancy than pheochromocytomas and skull base and neck paragangliomas [<xref ref-type="bibr" rid="paragangliomas.REF.proye.1992.651">Proye et al 1992</xref>], it is not clear whether this effect is the result of location, variant status, or both [<xref ref-type="bibr" rid="paragangliomas.REF.lima.2007.4853">Lima et al 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.klein.2008.94">Klein et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Although less common than malignant extra-adrenal sympathetic paragangliomas, malignant pheochromocytomas do occur, and may be more common in individuals with a germline <italic toggle="yes">SDHB</italic> pathogenic variant than in those with a germline <italic toggle="yes">SDHD</italic> or <italic toggle="yes">SDHC</italic> pathogenic variant or with a sporadic pheochromocytoma.</p>
            </list-item>
            <list-item>
              <p>Skull base and neck paragangliomas in persons with a germline <italic toggle="yes">SDHD</italic> pathogenic variant, in particular, are more likely to be multifocal than in persons with sporadic tumors or those with a germline <italic toggle="yes">SDHB</italic> pathogenic variant [<xref ref-type="bibr" rid="paragangliomas.REF.boedeker.2005.55">Boedeker et al 2005</xref>]. However, phenotypes vary among individuals and even among family members with the same pathogenic variant.</p>
              <p>Note: Despite the common association of <italic toggle="yes">SDHD</italic> pathogenic variants with skull base and neck paragangliomas, variation in the prevalence, penetrance, and phenotypic expression of SDH subunit pathogenic variants may be population specific [<xref ref-type="bibr" rid="paragangliomas.REF.lima.2007.4853">Lima et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>Germline <italic toggle="yes">SDHC</italic> pathogenic variants appear to be primarily (but not exclusively) associated with skull base and neck paragangliomas [<xref ref-type="bibr" rid="paragangliomas.REF.schiavi.2005.2057">Schiavi et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.mannelli.2007.586">Mannelli et al 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pasini.2008.79">Pasini et al 2008</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.peczkowska.2008.111">Peczkowska et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Approximately 75% of pheochromocytomas and sympathetic paragangliomas in persons with germline <italic toggle="yes">SDHD</italic> pathogenic variants reportedly occur when the pathogenic variant is in the 5&#x02019; portion of the gene [<xref ref-type="bibr" rid="paragangliomas.REF.eng.2003.193">Eng et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>A possible relationship between <italic toggle="yes">SDHB</italic> exon 1 deletions and abdominal extra-adrenal PGLs has been proposed [<xref ref-type="bibr" rid="paragangliomas.REF.casc_n.2008.233">Casc&#x000f3;n et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Germline <italic toggle="yes">SDHA</italic> pathogenic variants have been seen with PCCs and PGLs (sympathetic and parasympathetic) [<xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2010.3011">Burnichon et al 2010</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.korpershoek.2011.e1472">Korpershoek et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>The germline pathogenic variant <xref ref-type="table" rid="paragangliomas.T.selected_sdhaf2_pathoge">p.Gly78Arg</xref> in <italic toggle="yes">SDHAF2</italic> has only been seen in association with skull base and neck PGLs [<xref ref-type="bibr" rid="paragangliomas.REF.hao.2009.1139">Hao et al 2009</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.bayley.2010.366">Bayley et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Germline pathogenic variants in <italic toggle="yes">MAX</italic> have been reported in association with PCCs. Some affected individuals go on to develop PGLs; all those who have done so presented with PCCs initially [<xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2012.2828">Burnichon et al 2012</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="paragangliomas.Penetrance">
          <title>Penetrance</title>
          <p><bold>Age-related penetrance.</bold> Pathogenic variants in the genes encoding the subunits of SDH appear to have a high but age-related penetrance (<xref ref-type="table" rid="paragangliomas.T.estimated_agerelated_pe">Table 3</xref>). Data, however, are limited [<xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.jafri.2013.898">Jafri et al 2013</xref>].</p>
          <table-wrap id="paragangliomas.T.estimated_agerelated_pe" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Estimated Age-Related Penetrance for <italic toggle="yes">SDHD</italic> and <italic toggle="yes">SDHB</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">
                    <italic toggle="yes">SDHD</italic>
                  </th>
                  <th id="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">
                    <italic toggle="yes">SDHB</italic>
                  </th>
                  <th id="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_3">Reference</th>
                </tr>
                <tr>
                  <th headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1" id="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age in Years</th>
                  <th headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1" id="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Penetrance</th>
                  <th headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2" id="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age in Years</th>
                  <th headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2" id="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Penetrance</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">30</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">48%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">30</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">29%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al [2006]</xref>&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">31</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">50%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">35</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">50%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al [2004]</xref>&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">40</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">73%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">40</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">45%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al [2006]</xref>&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">50</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_1 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">86%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">50</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_2 hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;50% - 77%</td>
                  <td headers="hd_h_paragangliomas.T.estimated_agerelated_pe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al [2004]</xref>&#x000a0;<sup>2</sup><break/><xref ref-type="bibr" rid="paragangliomas.REF.jafri.2013.898">Jafri et al [2013]</xref>&#x000a0;<sup>3</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="paragangliomas.TF.3.1">
                <label>1. </label>
                <p>The age-related penetrance was higher in persons with a germline <italic toggle="yes">SDHD</italic> pathogenic variant than in persons with a germline <italic toggle="yes">SDHB</italic> pathogenic variant.</p>
              </fn>
              <fn id="paragangliomas.TF.3.2">
                <label>2. </label>
                <p>The difference in age-related penetrance between individuals with <italic toggle="yes">SDHB</italic> and <italic toggle="yes">SDHD</italic> pathogenic variants was not statistically significant.</p>
              </fn>
              <fn id="paragangliomas.TF.3.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="paragangliomas.REF.jafri.2013.898">Jafri et al [2013]</xref> found overall penetrance of <italic toggle="yes">SDHB</italic> pathogenic variants to be &#x0003c;50%.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Site-related penetrance.</bold> Estimated penetrance for skull base and neck paragangliomas and extra-adrenal abdominal or thoracic tumors is shown in <xref ref-type="table" rid="paragangliomas.T.estimated_siterelated_p">Table 4</xref> [<xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al 2006</xref>].</p>
          <table-wrap id="paragangliomas.T.estimated_siterelated_p" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Estimated Site-Related Penetrance for <italic toggle="yes">SDHD</italic> and <italic toggle="yes">SDHB</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Tumor Sites</th>
                  <th id="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Penetrance</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Skull base and neck paragangliomas&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">SDHD</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">68%</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                    <italic toggle="yes">SDHB</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">15%</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Extra-adrenal abdominal or thoracic tumors&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">SDHD</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">35%</td>
                </tr>
                <tr>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                    <italic toggle="yes">SDHB</italic>
                  </td>
                  <td headers="hd_h_paragangliomas.T.estimated_siterelated_p_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">69%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="paragangliomas.TF.4.1">
                <label>1. </label>
                <p>By age 40 years</p>
              </fn>
              <fn id="paragangliomas.TF.4.2">
                <label>2. </label>
                <p>By age 60 years</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="paragangliomas.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation is not observed in the PGL/PCC syndromes.</p>
        </sec>
        <sec id="paragangliomas.Nomenclature">
          <title>Nomenclature</title>
          <p>The PGL/PCC syndromes were initially referred to as the hereditary paraganglioma syndromes prior to the discovery of their association with pheochromocytomas.</p>
          <p>The diseases included in the designation PGL/PCC syndromes are named for the specific loci involved: PGL1 (<italic toggle="yes">SDHD</italic>), PGL2 (<italic toggle="yes">SDHAF2</italic>, also known as <italic toggle="yes">SDH5</italic>), PGL3 (<italic toggle="yes">SDHC</italic>), and PGL4 (<italic toggle="yes">SDHB</italic>).</p>
        </sec>
        <sec id="paragangliomas.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of pheochromocytoma/paraganglioma is not precisely known. The incidence of these tumors appears to be approximately 1:300,000/year.</p>
        </sec>
      </sec>
      <sec id="paragangliomas.Genetically_Related_Allel">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Evidence suggests that the Carney-Stratakis dyad, which includes paragangliomas and gastrointestinal stromal tumors (GISTs), is caused by <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHD</italic>, or <italic toggle="yes">SDHC</italic> pathogenic variants in some individuals [<xref ref-type="bibr" rid="paragangliomas.REF.mcwhinney.2007.1054">McWhinney et al 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pasini.2008.79">Pasini et al 2008</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.tenorio_jim_nez.2012.181">Tenorio Jim&#x000e9;nez et al 2012</xref>].</p>
        <p>Germline <italic toggle="yes">SDHB</italic> pathogenic variants have been reported with renal cell carcinoma [<xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.ricketts.2008.1260">Ricketts et al 2008</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.ricketts.2010.41">Ricketts et al 2010</xref>]. One individual with a renal cell carcinoma and an <italic toggle="yes">SDHD</italic> pathogenic variant has also been described [<xref ref-type="bibr" rid="paragangliomas.REF.ricketts.2010.41">Ricketts et al 2010</xref>], as well as a few individuals with an <italic toggle="yes">SDHB</italic> or an <italic toggle="yes">SDHD</italic> pathogenic variant who had thyroid carcinoma [<xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.ricketts.2010.41">Ricketts et al 2010</xref>].</p>
        <p>Homozygous and compound heterozygous pathogenic variants in <italic toggle="yes">SDHA</italic> are associated with Leigh syndrome, a neurodegenerative mitochondrial encephalomyopathy [<xref ref-type="bibr" rid="paragangliomas.REF.bourgeron.1995.144">Bourgeron et al 1995</xref>].</p>
      </sec>
      <sec id="paragangliomas.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are within the differential diagnosis for all individuals with paragangliomas and pheochromocytomas.</p>
        <p>Most inherited paragangliomas and pheochromocytomas are attributable to pathogenic variants in <italic toggle="yes">VHL</italic>, <italic toggle="yes">RET</italic>, <italic toggle="yes">NF1</italic>, <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC</italic>, <italic toggle="yes">SDHD</italic>, <italic toggle="yes">SDHAF2</italic>, <italic toggle="yes">TMEM127</italic>, and <italic toggle="yes">MAX</italic>. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/171300">Pheochromocytoma: OMIM Phenotype Series</ext-link>.</p>
        <p>Of all affected individuals in whom a germline pathogenic variant is found, 90% will have a pathogenic variant in <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHD</italic>, <italic toggle="yes">VHL</italic>, <italic toggle="yes">RET</italic> or <italic toggle="yes">NF1</italic>. Only 10% will have a pathogenic variant in <italic toggle="yes">SDHC, SDHA</italic>, <italic toggle="yes">SDGAF2</italic>, <italic toggle="yes">TMEM127</italic>, or <italic toggle="yes">MAX.</italic></p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">MAX</italic>-associated susceptibility to pheochromocytoma. In 1694 individuals with PGL/PCC from 17 independent referral centers, a germline pathogenic variant in <italic toggle="yes">MAX</italic> was found in 1.12% [<xref ref-type="bibr" rid="paragangliomas.REF.burnichon.2012.2828">Burnichon et al 2012</xref>]. All affected individuals had PCCs; some went on to develop PGLs.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">TMEM127</italic>-associated susceptibility to pheochromocytoma. Germline <italic toggle="yes">TMEM127</italic> pathogenic variants have only been reported with PCCs and not with PGLs [<xref ref-type="bibr" rid="paragangliomas.REF.yao.2010.2611">Yao et al 2010</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.abermil.2012.e805">Abermil et al 2012</xref>].</p>
          </list-item>
        </list>
        <p>Pheochromocytomas and catecholamine-secreting paragangliomas are also found in the following disorders:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter"><bold>Neurofibromatosis type I</bold></related-object>
<bold>(NF1),</bold> an autosomal dominant disorder caused by mutation of <italic toggle="yes">NF1</italic>. NF1 is characterized by multiple caf&#x000e9; au lait spots, axillary and inguinal freckling, multiple cutaneous neurofibromas, and iris Lisch nodules. Learning disabilities are present in at least 50% of individuals with NF1. Gastrointestinal stromal tumors (GISTs) [<xref ref-type="bibr" rid="paragangliomas.REF.stewart.2007a.e61">Stewart et al 2007a</xref>] and carcinoid tumors [<xref ref-type="bibr" rid="paragangliomas.REF.stewart.2007b.147">Stewart et al 2007b</xref>] have also been reported in individuals with NF1.</p>
            <p>Although pheochromocytomas are rare in NF1, their frequency is as high as 20%-50% in individuals with NF1 and hypertension. Most (84%) pheochromocytomas are unilateral. Extra-adrenal sympathetic paragangliomas can occur. These tumors are benign in most cases.</p>
            <p>Because <italic toggle="yes">NF1</italic> is large and there do not appear to be discrete mutation &#x0201c;hot spots&#x0201d; associated with development of pheochromocytoma [<xref ref-type="bibr" rid="paragangliomas.REF.bausch.2007.2784">Bausch et al 2007</xref>], genetic testing for <italic toggle="yes">NF1</italic> pathogenic variants is not routinely performed. NF1 is usually diagnosed clinically at an early age, and generally is easily distinguished from the hereditary PGL/PCC syndromes [<xref ref-type="bibr" rid="paragangliomas.REF.jim_nez.2006.2851">Jim&#x000e9;nez et al 2006</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="vhl" document-type="chapter"><bold>Von Hippel-Lindau disease</bold></related-object>
<bold>(VHL),</bold> an autosomal dominant disorder caused by mutation of <italic toggle="yes">VHL</italic>. VHL is characterized by hemangioblastomas of the brain, spinal cord, and retina; renal cysts and clear cell renal cell carcinoma; pheochromocytoma, pancreatic cysts and neuroendocrine tumors; endolymphatic sac tumors; and epididymal and broad ligament cysts.</p>
            <p>The frequency of pheochromocytoma in individuals with VHL is 10%-20% overall but varies by disease subtype. The mean age of onset of pheochromocytoma in VHL is approximately 30 years, although some individuals present with this neoplasm before age ten years [<xref ref-type="bibr" rid="paragangliomas.REF.lonser.2003.2059">Lonser et al 2003</xref>]. Pheochromocytomas occur in only 6%-9% of individuals with VHL type 1; the prevalence rises to 40%-59% in persons with type 2 disease. In type 2C VHL, pheochromocytomas are the sole manifestation of the syndrome and may present as simplex cases.</p>
            <p>Approximately 50% of pheochromocytomas are bilateral. Pheochromocytomas in VHL secrete primarily norepinephrine and normetanephrine. Approximately 5% of VHL-related catecholamine-secreting tumors become malignant, most commonly extra-adrenal sympathetic paragangliomas [<xref ref-type="bibr" rid="paragangliomas.REF.maher.2004.833">Maher 2004</xref>]. Extra-adrenal sympathetic paragangliomas occur infrequently [<xref ref-type="bibr" rid="paragangliomas.REF.jim_nez.2006.2851">Jim&#x000e9;nez et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>].</p>
            <p>VHL can be distinguished from hereditary PGL/PCC syndromes on clinical grounds in many instances, but may require molecular genetic testing [<xref ref-type="bibr" rid="paragangliomas.REF.jim_nez.2006.2851">Jim&#x000e9;nez et al 2006</xref>]. When sequence analysis and deletion/duplication analysis are used, the sensitivity of molecular genetic testing for VHL approaches 100% [<xref ref-type="bibr" rid="paragangliomas.REF.lonser.2003.2059">Lonser et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="men2" document-type="chapter"><bold>Multiple endocrine neoplasia type 2</bold></related-object>
<bold>(MEN2),</bold> an autosomal dominant syndrome caused by mutation of <italic toggle="yes">RET</italic>. The MEN2A subtype is characterized by medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism; MEN2A accounts for more than 80% of cases of MEN2. The MEN2B subtype lacks hyperparathyroidism but includes mucocutaneous neuromas and/or diffuse ganglioneuromatosis of the gastroenteric mucosa, slender body habitus, joint laxity, and skeletal malformations. MEN2B accounts for approximately 5% of MEN2. The subtype familial medullary thyroid carcinoma (FMTC) has medullary thyroid carcinoma as its only feature.</p>
            <p>Approximately 50% of individuals with MEN2A and MEN2B develop pheochromocytoma; it is the first manifestation of disease in 25% of affected individuals. Pheochromocytomas are bilateral in 50%-80% of cases but are almost always benign. The tumors primarily secrete epinephrine and metanephrine. Sympathetic extra-adrenal paragangliomas rarely occur in MEN2 [<xref ref-type="bibr" rid="paragangliomas.REF.erickson.2001.5210">Erickson et al 2001</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.jim_nez.2006.2851">Jim&#x000e9;nez et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.marini.2006.45">Marini et al 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>].</p>
            <p>Medullary thyroid cancer is the most common presenting feature of MEN2. MEN2 is often suspected on the basis of family history; individuals with pheochromocytomas infrequently present as simplex cases.</p>
          </list-item>
          <list-item>
            <p><bold>Carney triad</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604287">604287</ext-link>) is an extremely rare disorder that primarily affects young women. As initially described in 1977, the classic Carney triad included extra-adrenal sympathetic paraganglioma, gastric stromal sarcoma, and pulmonary chondroma. Adrenal cortical adenoma and esophageal leiomyoma were later shown to be associated with the syndrome [<xref ref-type="bibr" rid="paragangliomas.REF.stratakis.2009.152">Stratakis 2009</xref>]. Carney found that 78% of affected individuals had two of the three classic tumors and 22% had all three neoplasms [<xref ref-type="bibr" rid="paragangliomas.REF.carney.1999.543">Carney 1999</xref>]. No pathogenic variants in genes associated with hereditary PGLs or hereditary GISTs have been found in any of the reported individuals [<xref ref-type="bibr" rid="paragangliomas.REF.matyakhina.2007.2938">Matyakhina et al 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.stratakis.2009.152">Stratakis 2009</xref>]. However, chromosomal changes that appeared to correlate with the syndrome, including possible loss of regions on the short arm (1p) and the long arm (1q) of chromosome 1, were noted. The additional neoplasms associated with this syndrome should differentiate it from the hereditary PGL/PCC syndromes.</p>
          </list-item>
          <list-item>
            <p><bold>Carney-Stratakis dyad</bold> (Carney-Stratakis syndrome) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/606864">606864</ext-link>) is the association of paragangliomas and GISTS described in <xref ref-type="bibr" rid="paragangliomas.REF.carney.2002.132">Carney &#x00026; Stratakis [2002]</xref>. Carney-Stratakis dyad appears to be distinct from the Carney triad. <xref ref-type="bibr" rid="paragangliomas.REF.carney.2002.132">Carney &#x00026; Stratakis [2002]</xref> described five families with paragangliomas and GISTs that appeared to be inherited in an autosomal dominant manner with incomplete penetrance. Paragangliomas occurred in the skull base and neck, thorax, and abdomen. Both secretory and nonsecretory tumors were identified. In six individuals from six unrelated families with the Carney-Stratakis dyad, <xref ref-type="bibr" rid="paragangliomas.REF.mcwhinney.2007.1054">McWhinney et al [2007]</xref> reported pathogenic variants in <italic toggle="yes">SDHB</italic> in three, <italic toggle="yes">SCHC</italic> in two, and <italic toggle="yes">SDHD</italic> in one. <xref ref-type="bibr" rid="paragangliomas.REF.tenorio_jim_nez.2012.181">Tenorio Jim&#x000e9;nez et al [2012]</xref> reported an individual with Carney-Stratakis dyad and a pathogenic variant in <italic toggle="yes">SDHD.</italic></p>
          </list-item>
        </list>
      </sec>
      <sec id="paragangliomas.Management">
        <title>Management</title>
        <sec id="paragangliomas.Evaluations_Following_Ini">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Imaging studies using MRI/CT, <sup>123</sup>I-MIBG, and possibly PET to localize tumors and quantify the disease burden</p>
            </list-item>
            <list-item>
              <p>Evaluation of individuals with extra-adrenal sympathetic paragangliomas and pheochromocytomas for blood pressure elevations, tachycardia, and other signs and symptoms of catecholamine hypersecretion that must be controlled prior to definitive therapy</p>
            </list-item>
            <list-item>
              <p>Consideration of evaluation for gastrointestinal stromal tumors (GISTs) in children, adolescents, or young adults who have unexplained gastrointestinal symptoms (e.g., abdominal pain, upper gastrointestinal bleeding, nausea, vomiting, difficulty swallowing) or who experience unexplained intestinal obstruction or anemia [<xref ref-type="bibr" rid="paragangliomas.REF.pasini.2008.79">Pasini et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Consideration of screening for renal cell carcinoma in individuals with <italic toggle="yes">SDHB</italic> pathogenic variants</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="paragangliomas.Treatment_of_Manifestatio">
          <title>Treatment of Manifestations</title>
          <p>Clinical practice guidelines for the management of individuals with PGL/PCC have recently been published [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-1498">full text</ext-link>; registration or institutional access required).</p>
          <p>The management of tumors in individuals with hereditary PGL/PCC syndromes resembles management of sporadic tumors [<xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>]; however, persons with hereditary PGL/PCC syndromes are more likely to have multiple tumors and multifocal and/or malignant disease than are those with sporadic tumors.</p>
          <p><bold>For secretory tumors,</bold> treatment is directed toward containing the disease through antagonism of catecholamine excess with pharmacologic adrenergic blockade prior to surgical removal; treatment for malignant tumors is directed toward surgical removal and mitigation of the deleterious effects of metastatic spread [<xref ref-type="bibr" rid="paragangliomas.REF.eisenhofer.2004.423">Eisenhofer et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.lenders.2005.665">Lenders et al 2005</xref>].</p>
          <p><bold>For nonsecretory skull base and neck paragangliomas,</bold> early detection allows for timely surgical resection and is believed to reduce operative morbidity and improve prognosis [<xref ref-type="bibr" rid="paragangliomas.REF.rinaldo.2004.458">Rinaldo et al 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.gujrathi.2005.339">Gujrathi &#x00026; Donald 2005</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>For carotid body and low vagal paragangliomas,</bold> surgical resection is the treatment of choice in almost all cases. Most are benign and can be completely excised.</p>
              <p>Note: In elderly individuals or those with clinically important comorbidities, surgery may be delayed and tumors monitored by serial imaging. Radiation therapy can also be considered in these patients [<xref ref-type="bibr" rid="paragangliomas.REF.gujrathi.2005.339">Gujrathi &#x00026; Donald 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>For jugulotympanic paragangliomas,</bold> small tumors can usually be removed without difficulty; resection of larger tumors may be associated with CSF leak, meningitis, stroke, hearing loss, cranial nerve palsy, or even death. Therefore, close observation with symptomatically guided surgery may be prudent. Radiation therapy can also be considered, but potential long-term risks include malignant transformation of the primary tumor and other radiation-induced malignancies. In selected patients, stereotactic radiosurgery may also be performed [<xref ref-type="bibr" rid="paragangliomas.REF.gujrathi.2005.339">Gujrathi &#x00026; Donald 2005</xref>].</p>
            </list-item>
          </list>
          <p><bold>For pheochromocytomas,</bold> surgery, preferably laparoscopic, is the treatment of choice [<xref ref-type="bibr" rid="paragangliomas.REF.lenders.2005.665">Lenders et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Preoperative.</bold> The chronic and acute effects of catecholamine hypersecretion from adrenal chromaffin tumors must be reversed preoperatively. Combined &#x003b1;- and &#x003b2;- adrenergic blockade is required to control blood pressure and prevent intraoperative hypertensive crises. Using the following approach, only 7% of patients undergoing catecholamine-secreting tumor resection at the Mayo Clinic needed postoperative hemodynamic management [<xref ref-type="bibr" rid="paragangliomas.REF.young.2006.21">Young 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.young.2011">Young 2011</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Alpha-adrenergic blockade starting at least seven to ten days preoperatively to allow for normalization of blood pressure and volume expansion. The dose of the alpha blocker is adjusted for a low normal systolic blood pressure for age.</p>
                </list-item>
                <list-item>
                  <p>A liberal sodium diet</p>
                </list-item>
                <list-item>
                  <p>Once adequate &#x003b1;-adrenergic blockade is achieved, initiation of &#x003b2;-adrenergic blockade (e.g., 3 days prior to surgery). The dose of the &#x003b2;-adrenergic blocker is adjusted for a target heart rate of 80 beats per minute.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Postoperative.</bold> Approximately one to two weeks after surgery, 24-hour urinary fractionated metanephrines and catecholamines and/or plasma fractionated metanephrines should be measured.</p>
              <list list-type="bullet">
                <list-item>
                  <p>If the levels are normal, resection of the biochemically active pheochromocytoma or paraganglioma should be considered complete.</p>
                </list-item>
                <list-item>
                  <p>If the levels are increased, an unresected second tumor and/or occult metastases should be suspected.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>In individuals with <italic toggle="yes">SDHB</italic> pathogenic variants,</bold> paragangliomas or pheochromocytomas should be resected as soon as possible after tumor discovery. Prompt resection is particularly important for extra-adrenal sympathetic paragangliomas because of their tendency to metastasize.</p>
        </sec>
        <sec id="paragangliomas.Prevention_of_Secondary_C">
          <title>Prevention of Secondary Complications</title>
          <p>Early detection through surveillance and removal of tumors may prevent or minimize complications related to mass effects, catecholamine hypersecretion, and malignant transformation.</p>
        </sec>
        <sec id="paragangliomas.Surveillance">
          <title>Surveillance</title>
          <p>Individuals known to have a hereditary PGL/PCC syndrome, individuals without clinical manifestations of a hereditary PGL/PCC syndrome but known to have a <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHB,</italic>
<italic toggle="yes">SDHC, SDHD,</italic>
<italic toggle="yes">SDHAF2,</italic> or <italic toggle="yes">MAX</italic> pathogenic variant, and relatives at risk based on family history who have not undergone DNA-based testing need regular clinical monitoring by a physician or medical team with expertise in treatment of hereditary PGL/PCC syndromes.</p>
          <p>Screening should begin at age ten years or at least ten years before the earliest age at diagnosis in the family. <xref ref-type="bibr" rid="paragangliomas.REF.benn.2006.827">Benn et al [2006]</xref> estimated that if lifelong screening were to begin at age ten years, disease would be detected in all persons with <italic toggle="yes">SDHD</italic> pathogenic variants and 96% of persons with <italic toggle="yes">SDHB</italic> pathogenic variants.</p>
          <p>Although no clear consensus has been developed regarding when, how, and how often biochemical studies and imaging should be done in at-risk individuals, it is reasonable to consider lifelong annual biochemical and clinical surveillance. The findings of these evaluations should guide imaging studies [<xref ref-type="bibr" rid="paragangliomas.REF.mannelli.2006.405">Mannelli 2006</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pacak.2007.92">Pacak et al 2007</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.lenders.2014">Lenders et al 2014</xref>]. Monitoring includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Twenty-four hour urinary excretion of fractionated metanephrines and catecholamines, and/or plasma fractionated metanephrines to detect metastatic disease, tumor recurrence, or the development of additional tumors</p>
            </list-item>
            <list-item>
              <p>Follow-up imaging by MRI, CT, 123I-MIBG, or FDG-PET if the fractionated metanephrine and/or catecholamine levels become elevated, or if the original tumor had minimal or no catecholamine/fractionated metanephrine excess. In some individuals the image modality that was most effective in identifying the original tumor may prove to be equally effective in surveillance. Given the concern for cumulative radiation exposure in individuals who harbor germline pathogenic variants in genes associated with PGL/PCC, MRI may be the preferable imaging modality, with CT and nuclear imaging modalities reserved to further characterize tumors that are detected.</p>
            </list-item>
            <list-item>
              <p>In persons with <italic toggle="yes">SDHD</italic> and <italic toggle="yes">SDHC</italic> pathogenic variants, periodic (e.g., every 2 years) MRI or CT of the skull base and neck to detect paragangliomas and periodic (e.g., every 4 years) body MRI or CT and <sup>123</sup>I-MIBG scintigraphy to detect paragangliomas or metastatic disease that may occur beyond the neck and skull base</p>
            </list-item>
            <list-item>
              <p>In persons with <italic toggle="yes">SDHB</italic> pathogenic variants, periodic (e.g., every 2 years) MRI or CT of the abdomen, thorax, and pelvis to detect paragangliomas and periodic (e.g., every 4 years) <sup>123</sup>I-MIBG scintigraphy to detect paragangliomas or metastatic disease that may not be detected with MRI or CT</p>
            </list-item>
            <list-item>
              <p>In individuals (especially children, adolescents, or young adults) who have unexplained gastrointestinal symptoms (e.g., abdominal pain, upper gastrointestinal bleeding, nausea, vomiting, difficulty swallowing) or who experience unexplained intestinal obstruction or anemia, consideration of evaluation for GISTs [<xref ref-type="bibr" rid="paragangliomas.REF.pasini.2008.79">Pasini et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Consideration of screening for renal cell carcinoma in individuals with an <italic toggle="yes">SDHB</italic> pathogenic variant</p>
            </list-item>
          </list>
        </sec>
        <sec id="paragangliomas.AgentsCircumstances_to_Av">
          <title>Agents/Circumstances to Avoid</title>
          <p>Penetrance of hereditary PGL/PCC syndromes may be increased in those who live in high altitudes or are chronically exposed to hypoxic conditions [<xref ref-type="bibr" rid="paragangliomas.REF.pachecoojeda.1988.856">Pacheco-Ojeda et al 1988</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.astrom.2003.228">Astrom et al 2003</xref>]. Avoidance of habitation at high altitudes and activities that promote long-term exposure to hypoxia should be considered.</p>
          <p>Activities such as cigarette smoking that predispose to chronic lung disease should be discouraged in persons who have a pathogenic variant in <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHB,</italic>
<italic toggle="yes">SDHC, SDHD, SDHAF2,</italic> or <italic toggle="yes">MAX</italic>.</p>
        </sec>
        <sec id="paragangliomas.Evaluation_of_Relatives_a">
          <title>Evaluation of Relatives at Risk</title>
          <p>Because early diagnosis and treatment is very likely to change the outcome for individuals (especially in the context of <italic toggle="yes">SDHB</italic> pathogenic variants, which portend aggressive disease), it is recommended that relatives at risk be offered genetic testing as early as possible when the family pathogenic variant is known.</p>
          <p>By age ten years or at least ten years before the earliest age at diagnosis in the family, presymptomatic testing, including genetic testing, should be offered to all first-degree relatives of an individual in whom a pathogenic variant in <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHB,</italic>
<italic toggle="yes">SDHC,</italic> and <italic toggle="yes">SDHD, SDHAF2,</italic> or <italic toggle="yes">MAX</italic> has been detected.</p>
          <p>Use of molecular genetic testing for early identification of at-risk family members improves diagnostic certainty and reduces the need for costly screening procedures in those at-risk family members who have not inherited a pathogenic variant. Early detection of tumors can facilitate surgical removal, decrease related morbidity, and potentially result in removal prior to malignant transformation or metastasis [<xref ref-type="bibr" rid="paragangliomas.REF.young.2002.4101">Young et al 2002</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>In families with a previously identified pathogenic variant, relatives who do not have the family-specific pathogenic variant are spared the cost and anxiety associated with regular clinical, biochemical, and imaging studies.</p>
            </list-item>
            <list-item>
              <p>Family members who have the family-specific pathogenic variant can be informed of their heightened risks for paragangliomas and pheochromocytomas and encouraged to undergo biochemical and imaging studies as described in <xref ref-type="sec" rid="paragangliomas.Surveillance">Surveillance</xref>.</p>
            </list-item>
          </list>
          <p>Note: Identification of the pathogenic variant (or the absence thereof) in an affected individual is essential for interpretation of negative molecular genetic test results in an at-risk asymptomatic relative.</p>
          <p>See <xref ref-type="sec" rid="paragangliomas.Related_Genetic_Counselin">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="paragangliomas.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>There are no published consensus management guidelines for the diagnosis and management of hereditary PGL/PCC during pregnancy. A high index of suspicion for these tumors in pregnant women is indicated, since there are other more common causes of hypertension during pregnancy (e.g., pre-eclampsia). Secretory PGLs/PCCs are more likely to present at any time during pregnancy (whereas pre-eclampsia is more common in the second or third trimester) and are typically not associated with weight gain, edema, proteinuria or thrombocytopenia. Individuals with PGLs/PCCs are more likely to present with palpitations, sweating pallor, orthostatic hypotension, and glucosuria, and the hypertension may be episodic.</p>
          <p>A 24-hour urine collection for fractionated metanephrines and catecholamines should be used as a first-line test, as there is little experience with the use of plasma fractionated metanephrines during pregnancy. MRI without gadolinium administration should be the first-line test used to localize the tumor, since CT will expose the fetus to radiation. Radioisotope imaging studies should be deferred until after pregnancy in non-lactating mothers for similar reasons.</p>
          <p>Surgery is the definitive treatment for these tumors, with appropriate alpha-adrenergic, and if needed, subsequent beta-adrenergic blockade to prevent a hypertensive crisis. Phenoxybenzamine is the alpha blocker of choice in both pregnant and non-pregnant individuals with catecholamine-secreting tumors [<xref ref-type="bibr" rid="paragangliomas.REF.reisch.2006.2331">Reisch et al 2006</xref>]. For intra-abdominal PGL/PCC, a laparoscopic surgical approach is ideal if the tumor size allows. After 24 weeks gestation, surgery may need to be delayed until fetal maturity is reached (~34 weeks) because of problems with tumor accessibility. An open surgical approach combined with elective C-section may need to be performed in these situations. A good outcome has only been described with vaginal delivery in select cases [<xref ref-type="bibr" rid="paragangliomas.REF.junglee.2007.1362">Junglee et al 2007</xref>].</p>
        </sec>
        <sec id="paragangliomas.Therapies_Under_Investiga">
          <title>Therapies Under Investigation</title>
          <p>Attempts to inhibit or regulate the effects of hypoxia-inducible factor (HIF) activation, for example by enhancing prolyl hydroxylase activity, are being investigated and could provide the basis for useful therapy in the hereditary PGL/PCC syndromes [<xref ref-type="bibr" rid="paragangliomas.REF.lee.2005.155">Lee et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.selak.2005.77">Selak et al 2005</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>One compound, R59949, enhances prolyl hydroxylase activity, preventing HIF1&#x003b1; accumulation in cell lines under both normal and hypoxic conditions [<xref ref-type="bibr" rid="paragangliomas.REF.temes.2005.24238">Temes et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Other drugs that cause downregulation of HIF include mTOR inhibitors, HSP90 inhibitors, HDAC inhibitors, thioredoxin-1 inhibitors, and some microtubule inhibitors.</p>
            </list-item>
          </list>
          <p>Vascular endothelial growth factor (VEGF) receptor inhibitors (e.g., SU11248 and BAY43-9006) could potentially be useful in treating hereditary PGL/PCC syndromes [<xref ref-type="bibr" rid="paragangliomas.REF.kaelin.2005.627">Kaelin 2005</xref>]. Other substances currently under investigation include tyrosine kinase inhibitors such as pazopanib and sunitinib.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="paragangliomas.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="paragangliomas.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>The hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are inherited in an autosomal dominant manner. Pathogenic variants in <italic toggle="yes">SDHD</italic> (PGL1) and possibly <italic toggle="yes">SDHAF2</italic> (PGL2) and <italic toggle="yes">MAX</italic> demonstrate parent-of-origin effects, and cause disease almost exclusively when they are paternal in origin [<xref ref-type="bibr" rid="paragangliomas.REF.baysal.2004.85">Baysal 2004</xref>].</p>
        </sec>
        <sec id="paragangliomas.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed with a hereditary PGL/PCC syndrome have inherited the pathogenic variant from a parent. However, the age-dependent penetrance and variable expressivity of <italic toggle="yes">SDHA, SDHB, SDHC</italic>, <italic toggle="yes">SDHD</italic>, <italic toggle="yes">SDHAF2</italic>, and <italic toggle="yes">MAX</italic> pathogenic variants, as well as the parent-of-origin effects associated with <italic toggle="yes">SDHD</italic>, <italic toggle="yes">SDHAF2</italic>, and <italic toggle="yes">MAX</italic> pathogenic variants, predict that a substantial number of individuals who have inherited these pathogenic variants will appear to be simplex cases.</p>
            </list-item>
            <list-item>
              <p>A proband with a hereditary PGL/PCC syndrome may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. In one study <italic toggle="yes">de novo</italic> pathogenic variants were identified in 2/24 persons with <italic toggle="yes">SDHD</italic> pathogenic variants; no <italic toggle="yes">de novo</italic> pathogenic variants were identified among 25 persons with <italic toggle="yes">SDHB</italic> pathogenic variants [<xref ref-type="bibr" rid="paragangliomas.REF.neumann.2004.943">Neumann et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility in simplex cases.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include testing for the pathogenic variant identified in the proband.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with a hereditary PGL/PCC syndrome may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations have been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected. This has been reported in individuals with <related-object link-type="booklink" source-id="gene" document-id="vhl" document-type="chapter">VHL</related-object> [<xref ref-type="bibr" rid="paragangliomas.REF.murgia.2000.114">Murgia et al 2000</xref>] and <italic toggle="yes">HIF2A</italic>-related polycythemia paraganglioma [<xref ref-type="bibr" rid="paragangliomas.REF.buffet.2014.e369">Buffet et al 2014</xref>].</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected or has a pathogenic variant in a PGL/PCC-related gene, the risk to the sibs of inheriting the pathogenic variant is 50%.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for a PGL/PCC syndrome because of the possibility of (age-related) reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a hereditary PGL/PCC syndrome has a 50% chance of inheriting the pathogenic variant:</p>
          <list list-type="bullet">
            <list-item>
              <p>An individual who inherits an <italic toggle="yes">SDHD,</italic>
<italic toggle="yes">SDHAF2</italic>, or <italic toggle="yes">MAX</italic> pathogenic variant from his/her mother is usually not at risk of developing disease (although each of his/her offspring is at a 50% risk of inheriting the disease-causing allele). However, exceptions occur: <xref ref-type="bibr" rid="paragangliomas.REF.pigny.2008.1609">Pigny et al [2008]</xref> reported a boy age 11 years with a maternally inherited <italic toggle="yes">SDHD</italic> pathogenic variant associated with skull base and neck paraganglioma.</p>
            </list-item>
            <list-item>
              <p>An individual who inherits an <italic toggle="yes">SDHD</italic>, <italic toggle="yes">SDHAF2</italic>, or <italic toggle="yes">MAX</italic> pathogenic variant from his/her father is at high risk of manifesting PGL and PCC.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the pathogenic variant status of the proband's parents and the biological relationship to the proband. If a parent is affected or has a pathogenic variant, risk can be determined by pedigree analysis and/or molecular genetic testing.</p>
        </sec>
        <sec id="paragangliomas.Related_Genetic_Counselin">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="paragangliomas.Evaluation_of_Relatives_a">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with a hereditary PGL/PCC syndrome has the pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="paragangliomas.Prenatal_Testing_and_Prei">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the a PGL/PCC-causing pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for PGL/PCC are possible.</p>
          <p>Requests for prenatal testing for conditions which (like hereditary PGL/PCC) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="paragangliomas.Resources">
        <title>Resources</title>
      </sec>
      <sec id="paragangliomas.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="paragangliomas.Molecular_Genetic_Pathoge">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The four nuclear genes responsible for hereditary PGL/PCC encode the four subunits of the mitochondrial enzyme succinate dehydrogenase (SDH), which catalyzes the conversion of succinate to fumarate in the Krebs cycle and serves as complex II of the electron transport chain. A fifth nuclear gene, <italic toggle="yes">SDHAF2</italic> (also known as <italic toggle="yes">SDH5</italic>) encodes a protein that appears to be necessary for flavination of another SDH subunit, SDHA, as well as stabilization of the SDH complex. The protein is therefore necessary for SDH function. These are collectively known as the <italic toggle="yes">SDHx</italic> genes.</p>
          <p>The role of <italic toggle="yes">EGLN1</italic>, <italic toggle="yes">KIF1B</italic>, <italic toggle="yes">IDH1</italic>, and <italic toggle="yes">FH</italic> in hereditary PGL/PCC is still unclear (see <xref ref-type="sec" rid="paragangliomas.Other">Other</xref>).</p>
          <p>It is believed that <italic toggle="yes">SDHA, SDHB, SDHC</italic>, <italic toggle="yes">SDHD,</italic> and <italic toggle="yes">SDHAF2</italic> act as tumor suppressor genes in accordance with the Knudson two-hit hypothesis. Thus, the first hit (an inactivating pathogenic variant in the first allele of the gene) is inherited as a germline variant, whereas the second hit (an inactivating pathogenic variant in the remaining allele of the same gene) occurs during mitosis of cells in somatic tissue(s). The second inactivating pathogenic variant may be the result of gross chromosomal rearrangements, recombination, single-nucleotide variants, or epigenetic changes that result in allelic inactivation.</p>
          <p>The common neural crest derivation of skull base and neck paragangliomas, sympathetic extra-adrenal paragangliomas, and pheochromocytomas accounts for their association within a single syndrome. Competing and possibly complementary theories propose to explain the relationship between succinate dehydrogenase/mitochondrial complex II pathogenic variants and tumor formation.</p>
          <p>The protein products of the genes implicated in hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes represent the four subunits of the mitochondrial enzyme succinate dehydrogenase. <italic toggle="yes">SDHAF2</italic> encodes a protein that appears to be required for flavination of SDHA. Succinate dehydrogenase catalyzes the conversion of succinate to fumarate in the Krebs cycle and serves as complex II of the electron transport chain and acts as a link between the two. The nuclear genes <italic toggle="yes">SDHD</italic> and <italic toggle="yes">SDHC</italic> code for two membrane-spanning proteins, subunits D and C that anchor the catalytic site to the inner mitochondrial membrane. Subunit B, an iron-sulfur protein encoded by the nuclear gene <italic toggle="yes">SDHB</italic>, is required for catalytic activity. This protein transfers the electrons released during the conversion of succinate to fumarate to coenzyme Q, which is bound to subunits D and C within the inner mitochondrial membrane [<xref ref-type="bibr" rid="paragangliomas.REF.eng.2003.193">Eng et al 2003</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.gottlieb.2005.857">Gottlieb &#x00026; Tomlinson 2005</xref>].</p>
          <p>One hypothesis for the mechanism of tumorigenesis mediated by homozygous inactivating pathogenic variants in <italic toggle="yes">SDHA</italic>, <italic toggle="yes">SDHB</italic>, <italic toggle="yes">SDHC</italic>, or <italic toggle="yes">SDHD</italic> proposes the generation of a pseudohypoxic state within cells resulting from elevations in cellular succinate concentrations and/or the increased production of reactive oxygen species. Increased succinate concentrations appear to stabilize the transcription factor HIF1&#x003b1; by inhibiting prolyl hydroxylases. HIF1&#x003b1; is thought to be continuously produced and degraded within the cell. Prolyl hydroxylase function is necessary for VHL protein-mediated ubiquitination, which leads to HIF1&#x003b1; degradation. By inhibiting prolyl hydroxylases, increased intracellular succinate concentrations result in increased HIF1&#x003b1; levels and upregulation of cellular hypoxia/angiogenesis pathways. Increased levels of HIF1&#x003b1; enhance glucose uptake and increase expression of angiogenic, growth, and mitogenic factors such as VEGF and platelet-derived growth factor &#x003b2; polypeptide (PDGF&#x003b2;), erythropoietin, and transforming growth factor &#x003b1; (TGF&#x003b1;) [<xref ref-type="bibr" rid="paragangliomas.REF.maher.2004.833">Maher 2004</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.gottlieb.2005.857">Gottlieb &#x00026; Tomlinson 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.pollard.2005.2231">Pollard et al 2005</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.selak.2005.77">Selak et al 2005</xref>].</p>
          <p>Note: Autosomal recessive pathogenic variants in <italic toggle="yes">SDHA</italic>, the gene encoding the fourth SDH subunit, are associated with late-onset optic atrophy and Leigh syndrome (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object> for a discussion of Leigh syndrome caused by mtDNA pathogenic variants), a neurodegenerative disorder characterized by early-onset, progressive encephalopathy. Pathogenic variants in <italic toggle="yes">SDHA</italic> have very recently been found to be associated with hereditary PGL/PCC syndromes.</p>
          <sec id="paragangliomas.SDHA">
            <title>
              <italic toggle="yes">SDHA</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SDHA</italic> comprises 15 exons and is approximately 39 kb in length. It encodes a 2390-bp transcript (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004168.3">NM_004168.3</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> There are known benign variants in <italic toggle="yes">SDHA</italic> along with variants of undetermined clinical significance. A database of benign and pathogenic variants for the SDH subunit genes is maintained by the Leiden University Medical Center (see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>).</p>
            <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="paragangliomas.T.selected_sdha_pathogeni">Table 5</xref>. Two pathogenic missense variants (p.Arg585Trp and p.Arg589Trp) and one pathogenic nonsense variant (p.Arg31Ter) have been reported in individuals with hereditary PGL/PCC. A database of normal and pathogenic variants for the SDH subunit genes is maintained by the Leiden University Medical Center (see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>).</p>
            <table-wrap id="paragangliomas.T.selected_sdha_pathogeni" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p>Selected <italic toggle="yes">SDHA</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.91C&#x0003e;T</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg31Ter</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004168.3">NM_004168.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/156416003">NP_004159.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1753C&#x0003e;T</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg585Trp</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1765C&#x0003e;T</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdha_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg589Trp</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">SDHA</italic> encodes encodes a flavoprotein subunit of succinate-ubiquinone oxidoreductase.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">SDHA</italic> result in reduced or absent succinate dehydrogenase function because of loss or dysfunction of the affected subunit, or failure of the SDH heterotetramer to assemble.</p>
          </sec>
          <sec id="paragangliomas.SDHB">
            <title>
              <italic toggle="yes">SDHB</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SDHB</italic> comprises eight exons and is approximately 40 kb in length. It encodes an 1162-bp transcript (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_003000.2">NM_003000.2</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> There are known benign variants in <italic toggle="yes">SDHB</italic> along with variants of undetermined clinical significance. A database of benign and pathogenic variants for the SDH subunit genes is maintained by the Leiden University Medical Center (see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>).</p>
            <p><bold>Pathogenic variants.</bold> Nonsense, missense, and splice site variants, intragenic deletions and insertions, and whole-gene <italic toggle="yes">SDHB</italic> deletions have been reported in individuals/pedigrees affected with hereditary paraganglioma syndromes. More than 100 pathogenic sequence variants have been described for <italic toggle="yes">SDHB</italic>. A database of normal and pathogenic variants for the SDH subunit genes is maintained by the Leiden University Medical Center (see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>). <italic toggle="yes">SDHB</italic> variants are predominantly found in exons 1-7.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">SDHB</italic> encodes succinate dehydrogenase (ubiquinone) iron-sulfur subunit, a 280-amino-acid protein (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_002991.2">NP_002991.2</ext-link>).</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">SDHB</italic> result in reduced or absent succinate dehydrogenase function because of loss or dysfunction of the affected subunit, or failure of the SDH heterotetramer to assemble.</p>
          </sec>
          <sec id="paragangliomas.SDHC">
            <title>
              <italic toggle="yes">SDHC</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SDHC</italic> has six exons and is more than 35 kb in length. It codes for a 2858-bp transcript (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_003001.3">NM_003001.3</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> There are known benign variants in <italic toggle="yes">SDHC</italic> along with variants of undetermined clinical significance. A database of normal and pathogenic variants for the SDH subunit genes is maintained by the Leiden University Medical Center (see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>).</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic nonsense, missense, splice site, and regulatory variants and exon deletions in <italic toggle="yes">SDHC</italic> have been reported in individuals and pedigrees affected with hereditary paraganglioma syndromes. Approximately 14 pathogenic sequence variants have been described for <italic toggle="yes">SDHC.</italic> The pathogenic variants are found throughout the coding region of the gene, with the exception of exon 3.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">SDHC</italic> encodes the succinate dehydrogenase cytochrome b560 subunit, a 169-amino acid protein (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_002992.1">NP_002992.1</ext-link>).</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">SDHC</italic> result in reduced or absent succinate dehydrogenase function because of loss or dysfunction of the affected subunit or failure of the SDH heterotetramer to assemble.</p>
          </sec>
          <sec id="paragangliomas.SDHD">
            <title>
              <italic toggle="yes">SDHD</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SDHD</italic> consists of four exons and produces a 1313-bp transcript. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> There are known benign variants in <italic toggle="yes">SDHD</italic> along with variants of undetermined clinical significance. A database of benign and pathogenic variants for the SDH subunit genes is maintained by the Leiden University Medical Center (see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>).</p>
            <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="paragangliomas.T.selected_sdhd_pathogeni">Table 6</xref>. Pathogenic nonsense, missense, and splice site variants, intragenic insertions and deletions, and a whole-gene deletion have been reported in <italic toggle="yes">SDHD</italic> in individuals and pedigrees affected with hereditary paraganglioma syndromes. More than 70 pathogenic sequence variants have been described for <italic toggle="yes">SDHD</italic> (see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>). <italic toggle="yes">SDHD</italic> pathogenic variants are distributed throughout the four exons of the gene. Three <italic toggle="yes">SDHD</italic> founder variants (p.Asp92Tyr, p.Leu139Pro, p.Leu95Pro) identified in the Dutch population account for most cases of hereditary PGL/PCC syndrome in this population. Additional founder variants have been proposed in other population groups.</p>
            <p>Two recurrent <italic toggle="yes">SDHD</italic> pathogenic variants (p.Pro81Leu, p.Arg38Ter) identified in the US appear to have arisen independently in some families [<xref ref-type="bibr" rid="paragangliomas.REF.taschner.2001.274">Taschner et al 2001</xref>, <xref ref-type="bibr" rid="paragangliomas.REF.baysal.2002.178">Baysal et al 2002</xref>].</p>
            <table-wrap id="paragangliomas.T.selected_sdhd_pathogeni" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p>Selected <italic toggle="yes">SDHD</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_3" valign="top" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3G&#x0003e;C</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met1Ile&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_003002.1">NM_003002.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_002993.1">NP_002993.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.112C&#x0003e;T</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg38Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.242C&#x0003e;T</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro81Leu</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.274G&#x0003e;T</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp92Tyr</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.284T&#x0003e;C</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu95Pro</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.416T&#x0003e;C</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhd_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu139Pro</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="paragangliomas.TF.6.1">
                  <label>1. </label>
                  <p>See <xref ref-type="table" rid="paragangliomas.T.summary_of_molecular_ge">Table 1</xref>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">SDHD</italic> encodes succinate dehydrogenase (ubiquinone) cytochrome b small subunit, a 159-amino-acid protein.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">SDHD</italic> result in reduced or absent succinate dehydrogenase function because of loss or dysfunction of the affected subunit or failure of the SDH heterotetramer to assemble.</p>
          </sec>
          <sec id="paragangliomas.SDHAF2">
            <title>
              <italic toggle="yes">SDHAF2</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SDHAF2</italic> (also known as <italic toggle="yes">SDH5</italic>) consists of four exons and produces a 501-bp transcript (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nucleotide/8923449">NM_017841.1</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> Benign variants and variants of uncertain significance have not yet been reported in the coding sequence of the gene.</p>
            <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="paragangliomas.T.selected_sdhaf2_pathoge">Table 7</xref>. Three individuals with hereditary PGL/PCC from the Dutch family described by <xref ref-type="bibr" rid="paragangliomas.REF.van_baars.1982.305">van Baars et al [1982]</xref> were identified as having a single-nucleotide change (c.232G&#x0003e;A) in exon 2 in <italic toggle="yes">SDHAF2</italic> (also known as <italic toggle="yes">SDH5</italic>), which resulted in a p.Gly78Arg alteration in the most conserved region of the protein. Four hundred unaffected control individuals did not have the pathogenic variant [<xref ref-type="bibr" rid="paragangliomas.REF.hao.2009.1139">Hao et al 2009</xref>].</p>
            <table-wrap id="paragangliomas.T.selected_sdhaf2_pathoge" orientation="portrait" position="anchor">
              <label>Table 7. </label>
              <caption>
                <p>Selected <italic toggle="yes">SDHAF2</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_paragangliomas.T.selected_sdhaf2_pathoge_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_paragangliomas.T.selected_sdhaf2_pathoge_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_paragangliomas.T.selected_sdhaf2_pathoge_1_1_1_3" valign="top" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_paragangliomas.T.selected_sdhaf2_pathoge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.232G&#x0003e;A</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhaf2_pathoge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly78Arg</td>
                    <td headers="hd_h_paragangliomas.T.selected_sdhaf2_pathoge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nucleotide/8923449">NM_017841.1</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/8923450">NP_060311.1</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">SDHAF2</italic> encodes succinate dehydrogenase assembly factor 2, composed of 166 amino acid residues.</p>
            <p><bold>Abnormal gene product.</bold> The <italic toggle="yes">SDHAF2</italic> protein appears to be required for SDHA flavination, stability of the SDH complex, and therefore the function of the SDH enzyme. Evidence suggests that the c.232G&#x0003e;A pathogenic variant in exon 2 of <italic toggle="yes">SDHAF2</italic> destabilizes the protein, impairing its interaction with <italic toggle="yes">SDHA.</italic></p>
          </sec>
          <sec id="paragangliomas.MAX">
            <title>
              <italic toggle="yes">MAX</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MAX</italic> consists of five exons and produces a 2068-bp transcript (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002382.3">NM_002382.3</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="paragangliomas" object-id="paragangliomas.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> Benign variants have been reported in the coding sequence of the gene.</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic missense, nonsense, and splicing variants and intragenic deletions have all been reported in individuals with hereditary PGL/PCC.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">MAX</italic> encodes a 160 amino acid-protein that is a dimerization component of the MYC-<bold>MAX</bold>-MXD1 network of basic helix-loop-helix leucine zipper (bHLHZ) transcription factors that regulate cell proliferation, differentiation, and apoptosis.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">MAX</italic> result in absence or dysfunction of its protein product, resulting in dysregulation of a number of genes involved in cell growth and cell death.</p>
          </sec>
          <sec id="paragangliomas.Other">
            <title>Other</title>
            <p>Genes possibly associated with PGL/PCC syndromes <italic toggle="yes">KIF1B</italic> and <italic toggle="yes">EGLN1</italic> (formerly known as <italic toggle="yes">PHD2</italic>) have been reported to be associated with hereditary PGL/PCC, but their clinical significance is still unclear. The role of <italic toggle="yes">KIF1B</italic> and <italic toggle="yes">EGLN1</italic> is unknown, and need not be considered for routine testing for PGL/PCC syndromes.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold><italic toggle="yes">KIF1B.</italic></bold> A germline <italic toggle="yes">KIF1B</italic> pathogenic variant has been reported in a single individual with PCC, although somatic pathogenic variants were seen in a handful of individuals with PCC where germline DNA was not available for testing [<xref ref-type="bibr" rid="paragangliomas.REF.schlisio.2008.884">Schlisio et al 2008</xref>]. Thus the role of <italic toggle="yes">KIF1B</italic> pathogenic variants in hereditary PGL/PCC is unclear.</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Germline <italic toggle="yes">KIF1B</italic> loss-of-function variants have been reported in individuals who had neuroblastoma [<xref ref-type="bibr" rid="paragangliomas.REF.schlisio.2008.884">Schlisio et al 2008</xref>].</p>
                  </list-item>
                  <list-item>
                    <p><italic toggle="yes">KIF1B</italic> encodes a protein that works as a monomeric motor for anterograde transport of mitochondria</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">EGLN1.</italic></bold> In 82 individuals with hereditary PCC who had tested negative for known susceptibility genes, no pathogenic variants were found in <italic toggle="yes">EGLN1</italic> [<xref ref-type="bibr" rid="paragangliomas.REF.astuti.2010.73">Astuti et al 2010</xref>].</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Germline <italic toggle="yes">EGLN1</italic> pathogenic variants have also been reported in individuals with familial erythrocytosis [<xref ref-type="bibr" rid="paragangliomas.REF.ladroue.2008.2685">Ladroue et al 2008</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>A germline <italic toggle="yes">EGLN1</italic> pathogenic variant has only been reported in one individual who had erythrocytosis and recurrent PGL [<xref ref-type="bibr" rid="paragangliomas.REF.ladroue.2008.2685">Ladroue et al 2008</xref>]. No tumors were reported in relatives with the same pathogenic variant; thus the role of <italic toggle="yes">EGLN1</italic> pathogenic variants in hereditary PGL/PCC is unclear.</p>
                  </list-item>
                  <list-item>
                    <p><italic toggle="yes">EGLN1</italic> encodes a protein that plays a critical role in regulating hypoxia inducible factor (HIF) levels in erythropoetin-producing cells in humans.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Succinate inhibition of prolyl hydroxylases may also cause a decrease in the apoptosis of neural crest precursors that normally occurs during development in response to reduction in nerve growth factor levels. Cells within this residual pool are hypothesized to subsequently undergo malignant transformation [<xref ref-type="bibr" rid="paragangliomas.REF.lee.2005.155">Lee et al 2005</xref>]. The kinesin KIF1B&#x003b2; was recently shown to act downstream of the prolyl hydroxylase, EGLN3, and to be necessary and sufficient for neuronal apoptosis. <italic toggle="yes">KIF1B</italic> maps to chromosome 1p36.2, which is frequently deleted in neural crest-derived tumors, providing further support for this hypothesis [<xref ref-type="bibr" rid="paragangliomas.REF.schlisio.2008.884">Schlisio et al 2008</xref>].</p>
              </list-item>
            </list>
          </sec>
        </sec>
      </sec>
      <sec id="paragangliomas.References">
        <title>References</title>
        <sec id="paragangliomas.Published_GuidelinesConse">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="paragangliomas.Published_GuidelinesConse.reflist0">
            <ref id="paragangliomas.REF.lenders.2014">
              <mixed-citation publication-type="web">Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. 2014. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-1498">online</ext-link> (registration or institutional access required). Accessed 2-8-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="paragangliomas.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="paragangliomas.Literature_Cited.reflist0">
            <ref id="paragangliomas.REF.abermil.2012.e805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abermil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillaud-Bataille</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venisse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manivet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guignat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drui</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chupin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Josseaume</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Affres</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>97</volume>
                <fpage>E805</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22419703</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.algecirasschimnich.2008.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Algeciras-Schimnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preissner</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grebe</surname>
                    <given-names>SKG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>93</volume>
                <fpage>91</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17940110</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.amar.2007.3822">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amar</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peyrard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlumberger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>A-P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plounin</surname>
                    <given-names>P-F</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>3822</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17652212</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.amar.2005.8812">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amar</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ajzenberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressac-de Paillerets</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabre</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chamontin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delemer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niccoli-Sire</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohmer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadoul</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strompf</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlumberger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic testing in pheochromocytoma and functional paraganglioma.</article-title>
                <source>J Clin Oncol</source>
                <volume>23</volume>
                <fpage>8812</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16314641</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.astrom.2003.228">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Astrom</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willett-Brozick</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aston</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect.</article-title>
                <source>Hum Genet</source>
                <volume>113</volume>
                <fpage>228</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">12811540</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.astuti.2001.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Astuti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latif</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallol</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sk&#x000f6;ldberg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Husebye</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>49</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">11404820</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.astuti.2010.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Astuti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricketts</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chowdhury</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonough</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gentle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlisio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenchappa</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaelin</surname>
                    <given-names>WG</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Ratcliffe</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latif</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.</article-title>
                <source>Endocr Relat Cancer</source>
                <volume>18</volume>
                <fpage>73</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">20959442</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.badenhop.2004.e99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Badenhop</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagan</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lord</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>ZG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e99</fpage>
                <pub-id pub-id-type="pmid">15235042</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.bausch.2007.2784">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bausch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borozdin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mautner</surname>
                    <given-names>VF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boehm</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harenberg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pawlu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letizia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvieri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnaldi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klingenberg-Noftz</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reisch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunaud</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacGregor</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palazzo</surname>
                    <given-names>FF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barontini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremens</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brabant</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pf&#x000e4;ffle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koschker</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohoefner</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohaupt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimm</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarzab</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <collab>European-American Phaeochromocytoma Registry Study Group</collab>
                </person-group>
                <year>2007</year>
                <article-title>Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>2784</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17426081</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.bayley.2010.366">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bayley</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunst</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampietro</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korpershoek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinojar-Gutierrez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmers</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefsloot</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermsen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vriends</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hes</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tops</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corssmit</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Knijff</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenders</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinjens</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Krijger</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.</article-title>
                <source>Lancet Oncol</source>
                <volume>11</volume>
                <fpage>366</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">20071235</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.baysal.2004.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Genomic imprinting and environment in hereditary paraganglioma.</article-title>
                <source>Am J Med Genet C Semin Med Genet</source>
                <volume>129C</volume>
                <fpage>85</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15264276</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.baysal.2000.848">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrell</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willett-Brozick</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawrence</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myssiorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Mey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PEM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornelisse</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devlin</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.</article-title>
                <source>Science</source>
                <volume>287</volume>
                <fpage>848</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">10657297</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.baysal.2002.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willett-Brozick</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawrence</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drovdlic</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savul</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLeod</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yee</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brackmann</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slattery</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrell</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>WS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>178</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">11897817</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.benn.2006.827">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Benn</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byth</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Croxson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elston</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimm</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murday</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niccoli-Sire</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasieka</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohmer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>91</volume>
                <fpage>827</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">16317055</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.boedeker.2005.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boedeker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ridder</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schipper</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Paragangliomas of the head and neck: diagnosis and treatment.</article-title>
                <source>Fam Cancer</source>
                <volume>4</volume>
                <fpage>55</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15883711</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.bourgeron.1995.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bourgeron</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chretien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birch-Machin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourgeois</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viegas-P&#x000e9;quignot</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;tig</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.</article-title>
                <source>Nat Genet.</source>
                <volume>11</volume>
                <fpage>144</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">7550341</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.brouwers.2006.4505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brouwers</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenhofer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tao</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kant</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>91</volume>
                <fpage>4505</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16912137</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.buffet.2014.e369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buffet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansuy</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;nara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebras</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heymann</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simian</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cariou</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <article-title>Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2014</year>
                <volume>99</volume>
                <fpage>E369</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">24276449</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.buffet.2012.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buffet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venisse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nau</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roncellin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Pottier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boussion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Travers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simian</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abermil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.</article-title>
                <source>Horm Metab Res</source>
                <volume>44</volume>
                <fpage>359</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">22517557</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.burnichon.2010.3011">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bri&#x000e8;re</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lib&#x000e9;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vescovo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivi&#x000e8;re</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tissier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jouanno</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;nit</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzagoloff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>SDHA is a tumor suppressor gene causing paraganglioma.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>19</volume>
                <fpage>3011</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">20484225</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.burnichon.2012.2828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casc&#x000f3;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comino-M&#x000e9;ndez</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abermil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglada-P&#x000e9;rez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Cubas</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amar</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barontini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Quir&#x000f3;s</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bignon</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blok</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bobisse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borrego</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chanson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiara</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corssmit</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giacch&#x000e8;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Krijger</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ercolino</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girerd</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-Garc&#x000ed;a</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-Gra&#x000f1;a</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guilhem</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hes</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honrado</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korpershoek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenders</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Let&#x000f3;n</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mensenkamp</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierre</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prodanov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quesada-Charneco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapizzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reisch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roncador</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Ferrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schillo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stegmann</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmers</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tops</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urioste</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beuschlein</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenhofer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.</article-title>
                <source>Clin Cancer Res.</source>
                <volume>18</volume>
                <fpage>2828</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">22452945</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.burnichon.2009.2817">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohmer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amar</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leboulleux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darrouzet</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niccoli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaillard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabolle</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coupier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thieblot</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecomte</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wion-Barbot</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venisse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>94</volume>
                <fpage>2817</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">19454582</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.carney.1999.543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): natural history, adrenocortical component, and possible familial occurrence.</article-title>
                <source>Mayo Clin Proc</source>
                <volume>74</volume>
                <fpage>543</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">10377927</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.carney.2002.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad.</article-title>
                <source>Am J Med Genet</source>
                <volume>108</volume>
                <fpage>132</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11857563</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.casc_n.2008.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casc&#x000f3;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Jimenez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diez-Hernandez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montero-Conde</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leskela</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leandro-Garcia</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leton</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Antona</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HPH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Molecular characterisation of a common SDHB deletion in paraganglioma patients.</article-title>
                <source>J Med Genet</source>
                <volume>45</volume>
                <fpage>233</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18057081</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.casc_n.2006.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casc&#x000f3;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montero-Conde</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Llorente</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercadillo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Let&#x000f3;n</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez-Antona</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Delgado</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delgado</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000ed;ez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rovira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000ed;az</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?</article-title>
                <source>Genes Chromosomes Cancer</source>
                <volume>45</volume>
                <fpage>213</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16258955</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.cominom_ndez.2011.663">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Comino-M&#x000e9;ndez</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gracia-Aznarez</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leandro-Garcia</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leton</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honrado</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos-Medina</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caronia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pita</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez-Grana</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Cubas</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglada-Perez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maliszewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bobisse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pica</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez-Lavado</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez-Morales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez-Neira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roncador</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Antona</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benitez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascon</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.</article-title>
                <source>Nat Genet</source>
                <volume>43</volume>
                <fpage>663</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21685915</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.dannenberg.2002.2061">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dannenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinjens</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Urk</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauw</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouwen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mooi</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Krijger</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Frequent germline succinate dehydrogenase subunit D mutations in patients with apparently sporadic parasympathetic paraganglioma.</article-title>
                <source>Clin Cancer Res</source>
                <volume>8</volume>
                <fpage>2061</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12114404</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.delellis.2004">
              <mixed-citation publication-type="book">DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. <italic toggle="yes">World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of Endocrine Organs.</italic> Lyon, France: IARC Press; 2004.</mixed-citation>
            </ref>
            <ref id="paragangliomas.REF.eisenhofer.2004.423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eisenhofer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornstein</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwers</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Krijger</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehnert</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manger</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maris</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shulkin</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischler</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Malignant pheochromocytoma: current status and initiatives for future progress.</article-title>
                <source>Endocr Relat Cancer</source>
                <volume>11</volume>
                <fpage>423</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">15369446</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.eng.2003.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiuru</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A role for mitochondrial enzymes in inherited neoplasia and beyond.</article-title>
                <source>Nat Rev Cancer</source>
                <volume>3</volume>
                <fpage>193</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">12612654</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.erickson.2001.5210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erickson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudva</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebersold</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heerden</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>86</volume>
                <fpage>5210</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">11701678</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.erlic.2009.6378">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erlic</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rybicki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golcher</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kann</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brauckhoff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ssig</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muresan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;ffler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reisch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schott</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassnacht</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fottner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pl&#x000f6;ckinger</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersenn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabolotny</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kollukch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaremchuk</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <collab>European-American Pheochromocytoma Study Group</collab>
                </person-group>
                <article-title>Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.</article-title>
                <source>Clin Cancer Res.</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>6378</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">19825962</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.gill.2010.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benn</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarkson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muljono</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer-Rochow</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidhu</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clifton-Bligh</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.</article-title>
                <source>Hum Pathol</source>
                <volume>41</volume>
                <fpage>805</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">20236688</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.gimenezroqueplo.2003.5615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rieubland</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crespin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nau</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khau Van Kien</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corvol</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>P-F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.</article-title>
                <source>Cancer Res</source>
                <volume>63</volume>
                <fpage>5615</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">14500403</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.gimenezroqueplo.2006.699">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehnert</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2006</year>
                <article-title>Phaeochromocytoma, new genes and screening strategies.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>65</volume>
                <fpage>699</fpage>
                <lpage>705</lpage>
                <pub-id pub-id-type="pmid">17121518</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.gottlieb.2005.857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>IPM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mitochondrial tumour suppressors: a genetic and biochemical update.</article-title>
                <source>Nat Rev Cancer</source>
                <volume>5</volume>
                <fpage>857</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">16327764</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.gujrathi.2005.339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gujrathi</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donald</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Current trends in the diagnosis and management of head and neck paragangliomas.</article-title>
                <source>Curr Opin Otolaryngol Head Neck Surg</source>
                <volume>13</volume>
                <fpage>339</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">16282761</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.hao.2009.1139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hao</surname>
                    <given-names>HX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalimonchuk</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schraders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dephoure</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayley</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunst</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffman</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bentz</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gygi</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winge</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutter</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.</article-title>
                <source>Science.</source>
                <volume>325</volume>
                <fpage>1139</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">19628817</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.jafri.2013.898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jafri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitworth</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rattenberry</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vialard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izatt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brennan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canham</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomkins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donaldson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barwell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylwin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ball</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srirangalingam</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chew</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irving</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <year>2013</year>
                <volume>78</volume>
                <fpage>898</fpage>
                <lpage>906</lpage>
                <pub-id pub-id-type="pmid">23072324</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.jim_nez.2006.2851">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jim&#x000e9;nez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cote</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagel</surname>
                    <given-names>RF</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>91</volume>
                <fpage>2851</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16735498</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.junglee.2007.1362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Junglee</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harries</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott-Coombes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scanlon</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Pheochromocytoma in pregnancy: when is operative intervention indicated?</article-title>
                <source>J Womens Health (Larchmt)</source>
                <volume>16</volume>
                <fpage>1362</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18001193</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.kaelin.2005.627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaelin</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>338</volume>
                <fpage>627</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">16153592</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.kimura.a">
              <mixed-citation publication-type="book">Kimura N, Capella C, De Krijger RR, Thompson LDR, Lam KY, Komminoth P, Tischler AS, Young WF. Extra-adrenal sympathetic paraganglioma: Superior and inferior paraaortic. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. <italic toggle="yes">World Health Organization Classification of Tumours, Tumours of Endocrine Organs.</italic> Lyon, France: IARC Press; 2004a:164-5.</mixed-citation>
            </ref>
            <ref id="paragangliomas.REF.kimura.b">
              <mixed-citation publication-type="book">Kimura N, Chetty R, Capella C, Young WF, Koch CA, Lam KY, DeLellis RA, Kawashima A, Komminoth P, Tischler AS. Extra-adrenal paraganglioma: Carotid body, jugulotympanic, vagal, laryngeal, aortico-pulmonary. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. <italic toggle="yes">World Health Organization Classification of Tumours, Tumours of Endocrine Organs.</italic> Lyon, France: IARC Press; 2004b:159-61.</mixed-citation>
            </ref>
            <ref id="paragangliomas.REF.klein.2008.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumilla</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.</article-title>
                <source>Diagn Mol Pathol.</source>
                <volume>17</volume>
                <fpage>94</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">18382370</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.korpershoek.2011.e1472">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korpershoek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gessel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudijk</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badoual</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadessaud</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venisse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayley</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dooren</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Herder</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tissier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nederveen</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinjens</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Krijger</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>96</volume>
                <fpage>E1472</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21752896</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.ladroue.2008.2685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ladroue</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carcenac</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leporrier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gad</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Hello</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galateau-Salle</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feunteun</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouyssegur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardie</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>PHD2 mutation and congenital erythrocytosis with paraganglioma.</article-title>
                <source>N Engl J Med</source>
                <volume>359</volume>
                <fpage>2685</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">19092153</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.lee.2005.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linggi</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sajan</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farese</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaelin</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlisio</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.</article-title>
                <source>Cancer Cell</source>
                <volume>8</volume>
                <fpage>155</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">16098468</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.lee.2003.1055">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chionh</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PEM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect?</article-title>
                <source>Laryngoscope</source>
                <volume>113</volume>
                <fpage>1055</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12782822</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.lenders.2014.1915">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lenders</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duh</surname>
                    <given-names>QY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenhofer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grebe</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murad</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naruse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <etal/>
                </person-group>
                <year>2014</year>
                <article-title>Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>99</volume>
                <fpage>1915</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">24893135</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.lenders.2005.665">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lenders</surname>
                    <given-names>JWM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenhofer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Phaeochromocytoma.</article-title>
                <source>Lancet</source>
                <volume>366</volume>
                <fpage>665</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">16112304</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.lima.2007.4853">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lima</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feij&#x000e3;o</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira da Silva</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira-Castro</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Ballester</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e1;ximo</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobrinho-Sim&#x000f5;es</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Rostan</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in Northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical pathological correlations.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>4853</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">17848412</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.lloyd.2004">
              <mixed-citation publication-type="book">Lloyd RV, Tischler AS, Kimura N, McNicol AM, Young WF. Adrenal tumours: Introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. <italic toggle="yes">World Health Organization Classification of Tumours, Tumours of Endocrine Organs.</italic> Lyon, France: IARC Press; 2004:137-8.</mixed-citation>
            </ref>
            <ref id="paragangliomas.REF.lonser.2003.2059">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lonser</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McClellan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chew</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Libutti</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfield</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>von Hippel-Lindau disease.</article-title>
                <source>Lancet</source>
                <volume>361</volume>
                <fpage>2059</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">12814730</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.maher.2004.833">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>von Hippel-Lindau disease.</article-title>
                <source>Curr Mol Med</source>
                <volume>4</volume>
                <fpage>833</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15579030</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.mannelli.2006.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Management and treatment of pheochromocytomas and paragangliomas.</article-title>
                <source>Ann NY Acad Sci</source>
                <volume>1073</volume>
                <fpage>405</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">17102109</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.mannelli.2007.586">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ercolino</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giache</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirami</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parenti</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Genetic screening for pheochromocytoma: should SDHC gene analysis be included?</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>586</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17557926</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.marini.2006.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falchetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Monte</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sala</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tognarini</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandi</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Multiple endocrine neoplasia type 2.</article-title>
                <source>Orphanet J Rare Dis</source>
                <volume>1</volume>
                <fpage>45</fpage>
                <pub-id pub-id-type="pmid">17105651</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.matyakhina.2007.2938">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bei</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasini</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunawan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stergiopoulos</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muchow</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dutra</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cid</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaillard</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assie</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuzesi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Genetics of Carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>2938</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">17535989</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.mcnicol.2004">
              <mixed-citation publication-type="book">McNicol AM, Young WF, Kawashima A, Komminoth P, Tischler AS. Benign phaeochromocytoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. <italic toggle="yes">World Health Organization Classification of Tumours, Tumours of Endocrine Organs.</italic> Lyon, France: IARC Press; 2004:151-5.</mixed-citation>
            </ref>
            <ref id="paragangliomas.REF.mcwhinney.2007.1054">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasini</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <collab>International Carney Triad and Carney-Stratakis Syndrome Consortium</collab>
                </person-group>
                <year>2007</year>
                <article-title>Familial gastrointestinal stromal tumors and germ-line mutations.</article-title>
                <source>N Engl J Med</source>
                <volume>357</volume>
                <fpage>1054</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17804857</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.murgia.2000.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murgia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinanzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perilongo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Somatic mosaicism in von Hippel-Lindau disease.</article-title>
                <source>Hum Mutat.</source>
                <year>2000</year>
                <volume>15</volume>
                <fpage>114</fpage>
                <pub-id pub-id-type="pmid">10612832</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.neumann.2002.1459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bausch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bender</surname>
                    <given-names>BU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimm</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schipper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klisch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altehoefer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaesker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apel</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reineke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoang-Vu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brauckhoff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein-Franke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klose</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maier-Woelfle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000e7;zkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szmigielski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2002</year>
                <article-title>Germ-line mutations in nonsyndromic pheochromocytoma.</article-title>
                <source>N Engl J Med</source>
                <volume>346</volume>
                <fpage>1459</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">12000816</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.neumann.2009.3650">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlic</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boedeker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rybicki</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermsen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falcioni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauters</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edelman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benn</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiegand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasp</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuck</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevilla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubaszek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pigny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Learoyd</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Croxson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabolotny</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaremchuk</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Draf</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muresan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knipping</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strohm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyckhoff</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthias</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reisch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preuss</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esser</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaftan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;ver</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fottner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorgulla</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malekpour</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zarandy</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schipper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brase</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glien</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;hnemund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koscielny</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwerdtfeger</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>V&#x000e4;lim&#x000e4;ki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szyfter</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ridder</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out.</article-title>
                <source>Cancer Res.</source>
                <volume>69</volume>
                <fpage>3650</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19351833</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.neumann.2004.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pawlu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bausch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muresan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klisch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bley</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoegerle</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boedeker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schipper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <collab>European-American Paraganglioma Study Group</collab>
                </person-group>
                <year>2004</year>
                <article-title>Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.</article-title>
                <source>JAMA</source>
                <volume>292</volume>
                <fpage>943</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15328326</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.niemann.2000.268">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niemann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations in SDHC cause autosomal dominant paraganglioma, type 3.</article-title>
                <source>Nat Genet</source>
                <volume>26</volume>
                <fpage>268</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11062460</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.pacak.2007.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenhofer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahlman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornstein</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>A-P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossman</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNicol</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischler</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Pheochromocytoma: recommendations for clinical practice from the First International Symposium.</article-title>
                <source>Nat Clin Pract Endocrinol Metab</source>
                <volume>3</volume>
                <fpage>92</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">17237836</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.pachecoojeda.1988.856">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pacheco-Ojeda</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durango</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vivar</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Carotid body tumors at high altitudes: Quito, Ecuador.</article-title>
                <source>World J Surg</source>
                <volume>12</volume>
                <fpage>856</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">3250136</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.pai.2014.1130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pai</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manipadam</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebenazer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajaratnam</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Usefulness of succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.</article-title>
                <source>APMIS</source>
                <volume>122</volume>
                <fpage>1130</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24735130</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.pasini.2008.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasini</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bei</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stergiopoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muchow</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrando</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assie</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chompret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briere</surname>
                    <given-names>J-J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>A-P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, SDHD.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>16</volume>
                <fpage>79</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">17667967</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.peczkowska.2008.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prejbisz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubaszek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cwikla</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furmanek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlic</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HPH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation.</article-title>
                <source>Nat Clin Pract Endocrinol Metab</source>
                <volume>4</volume>
                <fpage>111</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18212813</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.pigny.2008.1609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pigny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauters</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Montpreville</surname>
                    <given-names>VT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crepin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porchet</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caron</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>93</volume>
                <fpage>1609</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">18211978</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.pollard.2005.2231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pollard</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briere</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alam</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barwell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barclay</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wortham</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olpin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moat</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hargreaves</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heales</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalgleish</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulsom</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>IPM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Accumulation of Krebs cycle intermediates and over-expression of HIF1&#x003b1; in tumours which result from germline FH and SDH mutations.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>2231</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15987702</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.proye.1992.651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Proye</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vix</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goropoulos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerlo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecomte-Houcke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>High incidence of malignant pheochromocytoma in a surgical unit: 26 cases out of 100 patients operated from 1971 to 1991.</article-title>
                <source>J Endocrinol Invest</source>
                <volume>15</volume>
                <fpage>651</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">1479148</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.reisch.2006.2331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reisch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Pheochromocytoma: presentation, diagnosis and treatment.</article-title>
                <source>J Hypertens.</source>
                <volume>24</volume>
                <fpage>2331</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17082709</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.ricketts.2008.1260">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ricketts</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Killick</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astuti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latif</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Germline SDHB mutations and familial renal cell carcinoma.</article-title>
                <source>J Natl Cancer Inst.</source>
                <volume>100</volume>
                <fpage>1260</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">18728283</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.ricketts.2010.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ricketts</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forman</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rattenberry</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradshaw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalloo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izatt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ball</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srirangalingam</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Killick</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylwin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murday</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chew</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connell</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blundell</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.</article-title>
                <source>Hum Mutat</source>
                <volume>31</volume>
                <fpage>41</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">19802898</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.rinaldo.2004.458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myssiorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devaney</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferlito</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Which paragangliomas of the head and neck have a higher rate of malignancy?</article-title>
                <source>Oral Oncol</source>
                <volume>40</volume>
                <fpage>458</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15006616</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.schiavi.2005.2057">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boedeker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bausch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuentes-Gomez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strassburg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pawlu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salzmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berlis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brink</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cybulla</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muresan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>V&#x000e4;lim&#x000e4;ki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawecki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szutkowski</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schipper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pigny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauters</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willet-Brozick</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.</article-title>
                <source>JAMA</source>
                <volume>294</volume>
                <fpage>2057</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16249420</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.schlisio.2008.884">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schlisio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenchappa</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vredeveld</surname>
                    <given-names>LCW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greulich</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahriari</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pigny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomeroy</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maris</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Look</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyerson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeper</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaelin</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The kinesin KIF1B&#x003b2; acts downstream from Eg1N3 to induce apoptosis and is a potential 1p36 tumor suppressor.</article-title>
                <source>Genes Dev</source>
                <volume>22</volume>
                <fpage>884</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">18334619</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.selak.2005.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selak</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armour</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKenzie</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulahbel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansfield</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-&#x003b1; prolyl hydroxylase.</article-title>
                <source>Cancer Cell</source>
                <volume>7</volume>
                <fpage>77</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">15652751</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.stewart.2007a.e61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corless</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubin</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinrich</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messiaen</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kessler</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <year>2007a</year>
                <article-title>Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>e61</fpage>
                <pub-id pub-id-type="pmid">17209131</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.stewart.2007b.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traynor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onen</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balsitis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upadhyaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobias</surname>
                    <given-names>ES</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene.</article-title>
                <source>Fam Cancer</source>
                <volume>6</volume>
                <fpage>147</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16944271</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.stratakis.2009.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.</article-title>
                <source>Mol Cell Endocrinol.</source>
                <year>2009</year>
                <volume>300</volume>
                <fpage>152</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19063937</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.taschner.2001.274">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000f6;cker-Vriends</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Mey</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ommen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornelisse</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.</article-title>
                <source>Genes Chromosomes Cancer</source>
                <volume>31</volume>
                <fpage>274</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11391798</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.temes.2005.24238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Temes</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Puig</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acosta-Iborra</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellanos</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feijoo-Cuaresma</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olmos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aragon&#x000e9;s</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landazuri</surname>
                    <given-names>MO</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase.</article-title>
                <source>J Biol Chem</source>
                <volume>280</volume>
                <fpage>24238</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">15849364</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.tenorio_jim_nez.2012.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tenorio Jim&#x000e9;nez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izatt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moonim</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carroll</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGowan</surname>
                    <given-names>BM</given-names>
                  </name>
                </person-group>
                <article-title>Carney Stratakis syndrome in a patient with SDHD mutation.</article-title>
                <source>Endocr Pathol.</source>
                <year>2012</year>
                <volume>23</volume>
                <fpage>181</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22638655</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.thompson.2004">
              <mixed-citation publication-type="book">Thompson LDR, Young WF, Kawashima A, Komminoth PM, Tischler AS. Malignant adrenal phaeochromocytoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. <italic toggle="yes">World Health Organization Classification of Tumours, Tumours of Endocrine Organs.</italic> Lyon, France: IARC Press; 2004:165-6.</mixed-citation>
            </ref>
            <ref id="paragangliomas.REF.timmers.2007.779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Timmers</surname>
                    <given-names>HJLM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozupa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenhofer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raygada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenders</surname>
                    <given-names>JWM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacak</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>779</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">17200167</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.tischler.2004">
              <mixed-citation publication-type="book">Tischler AS, Komminoth P. Extra-adrenal sympathetic paraganglioma: Cervical, intrathoracic and urinary bladder. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. <italic toggle="yes">World Health Organization Classification of Tumours, Tumours of Endocrine Organs</italic>. Lyon, France: IARC Press; 2004:165-6.</mixed-citation>
            </ref>
            <ref id="paragangliomas.REF.van_baars.1982.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Baars</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Broek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geerts</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veldman</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>Genetic aspects of nonchromaffin paraganglioma.</article-title>
                <source>Hum Genet</source>
                <volume>60</volume>
                <fpage>305</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">6286462</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.van_nederveen.2006.177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Nederveen</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinjens</surname>
                    <given-names>WNM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korpershoek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Krijger</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The occurrence of SDHB gene mutations in pheochromocytoma.</article-title>
                <source>Ann NY Acad Sci</source>
                <volume>1073</volume>
                <fpage>177</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17102084</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.vanderveen.2009.1158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanderveen</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callstrom</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farley</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>GB</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Biopsy of pheochromocytomas and paragangliomas: potential for disaster.</article-title>
                <source>Surgery</source>
                <volume>146</volume>
                <fpage>1158</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">19958944</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.vanharanta.2004.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanharanta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Virta</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehtonen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juhola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklin</surname>
                    <given-names>J-P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pukkala</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiuru</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nupponen</surname>
                    <given-names>NN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HPH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.</article-title>
                <source>Am J Hum Genet</source>
                <volume>74</volume>
                <fpage>153</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14685938</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.welander.2011.r253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Welander</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f6;derkvist</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimm</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.</article-title>
                <source>Endocr Relat Cancer.</source>
                <volume>18</volume>
                <fpage>R253</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">22041710</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.yao.2010.2611">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglada-Perez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toledo</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ercolino</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapizzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricketts</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giacche</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boaretto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iacobone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biondi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lima-Junior</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kater</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bex</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossman</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruber</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barontini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toledo</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robledo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.</article-title>
                <source>JAMA</source>
                <volume>304</volume>
                <fpage>2611</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21156949</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.young.2002.4101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>87</volume>
                <fpage>4101</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12213855</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.young.2006.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Paragangliomas: clinical overview.</article-title>
                <source>Ann NY Acad Sci</source>
                <volume>1073</volume>
                <fpage>21</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17102068</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.young.2007.601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Clinical practice. The incidentally discovered adrenal mass.</article-title>
                <source>N Engl J Med</source>
                <volume>356</volume>
                <fpage>601</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">17287480</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.young.2011">
              <mixed-citation publication-type="book">Young WF Jr. Endocrine hypertension. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. <italic toggle="yes">Williams Textbook of Endocrinology.</italic> 12 ed. Philadelphia, PA: Saunders Elsevier Inc; 2011:545-80.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="paragangliomas.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="paragangliomas.Suggested_Reading.reflist0">
            <ref id="paragangliomas.REF.bausch.2006.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bausch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boedeker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berlis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brink</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cybulla</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walz</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januszewicz Letizia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic and clinical investigation of pheochromocytoma: a 22-year experience, from Freiburg, Germany to international effort.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>122</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">17102079</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.bayley.2005.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bayley</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.</article-title>
                <source>BMC Med Genet</source>
                <volume>6</volume>
                <fpage>39</fpage>
                <pub-id pub-id-type="pmid">16288654</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.bayley.2006.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bayley</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Minderhout</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oomen</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menko</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasini</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrando</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alpert</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blair</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.</article-title>
                <source>BMC Med Genet</source>
                <volume>7</volume>
                <fpage>1</fpage>
                <pub-id pub-id-type="pmid">16405730</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.baysal.2002.617">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Hereditary paraganglioma targets diverse paraganglia.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>617</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">12205103</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.baysal.2001.495">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinstein</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Phenotypic dichotomy in mitochondrial complex II genetic disorders.</article-title>
                <source>J Mol Med</source>
                <volume>79</volume>
                <fpage>495</fpage>
                <lpage>503</lpage>
                <pub-id pub-id-type="pmid">11692162</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.baysal.2004.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baysal</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willett-Brozick</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filho</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawrence</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrell</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>703</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15342702</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.benn.2006.104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Benn</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsh</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic testing in pheochromocytoma- and paraganglioma-associated syndrome.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>104</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">17102077</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.benn.2006.435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Benn</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic basis of phaeochromocytoma and paraganglioma.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab</source>
                <volume>20</volume>
                <fpage>435</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">16980204</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.boedeker.2007.126">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boedeker</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bausch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schipper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ridder</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Malignant head and neck paragangliomas in SDHB mutation carriers.</article-title>
                <source>Otolaryngol Head Neck Surg</source>
                <volume>137</volume>
                <fpage>126</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17599579</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.bornstein.2006.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bornstein</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic testing in pheochromocytoma: increasing importance for clinical decision making.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>94</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">17102076</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.braun.2005.2809">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riemann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kupka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leistenschneider</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotlar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmid</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blin</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas.</article-title>
                <source>Anticancer Res</source>
                <volume>25</volume>
                <fpage>2809</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16080530</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.bryant.2003.1196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bryant</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farmer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kessler</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Townsend</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathanson</surname>
                    <given-names>KL</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Pheochromocytoma: the expanding genetic differential diagnosis.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>95</volume>
                <fpage>1196</fpage>
                <lpage>204</lpage>
                <pub-id pub-id-type="pmid">12928344</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.castellano.2006.156">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castellano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giacch&#x000e8;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agliozzo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tosini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panarotto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappelli</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulatero</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cumetti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veglio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agabiti-Rosei</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>156</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">17102082</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.dahia.2006.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Evolving concepts in pheochromocytoma and paraganglioma.</article-title>
                <source>Curr Opin Oncol</source>
                <volume>18</volume>
                <fpage>1</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16357557</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.dahia.2006.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                  <collab>Familial Pheochromocytoma Consortium</collab>
                </person-group>
                <year>2006</year>
                <article-title>Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>208</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">17102089</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.gimenezroqueplo.2001.1186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mourad</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plouin</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corvol</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;tig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeunemaitre</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>1186</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">11605159</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.hensen.2004.4076">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hensen</surname>
                    <given-names>EF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Minderhout</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogendoorn</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Mey</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devilee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornelisse</surname>
                    <given-names>CJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families.</article-title>
                <source>Oncogene</source>
                <volume>23</volume>
                <fpage>4076</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">15064708</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.ishii.2005.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishii</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akatsuka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hino</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartman</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishii</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis.</article-title>
                <source>Cancer Res</source>
                <volume>65</volume>
                <fpage>203</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15665296</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.isobe.2007.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Isobe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minowada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatsuno</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzukawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nissato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanmoku</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yashiro</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takekoshi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Novel germline mutations in the SDHB and SDHD genes in Japanese pheochromocytomas.</article-title>
                <source>Horm Res</source>
                <volume>68</volume>
                <fpage>68</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">17308434</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.jiang.2011.2133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Minireview: the busy road to pheochromocytomas and paragangliomas has a new member, TMEM127.</article-title>
                <source>Endocrinology</source>
                <volume>152</volume>
                <fpage>2133</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21447639</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.korpershoek.2006.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korpershoek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Nederveen</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dannenberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petri</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komminoth</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenders</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhofstad</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Herder</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Krijger</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinjens</surname>
                    <given-names>WN</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>138</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">17102080</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.maher.2002.2347">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The pressure rises: update on the genetics of phaeochromocytoma.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>2347</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">12351569</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.mannelli.2007.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaglian&#x000f2;</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ercolino</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becherini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parenti</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Genetics and biology of pheochromocytoma.</article-title>
                <source>Exp Clin Endocrinol Diabetes</source>
                <volume>115</volume>
                <fpage>160</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17427103</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.martin.2007.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irving</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The genetics of paragangliomas: a review.</article-title>
                <source>Clin Otolaryngol</source>
                <volume>32</volume>
                <fpage>7</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">17298303</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.maxwell.2005.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maxwell</surname>
                    <given-names>PH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A common pathway for genetic events leading to pheochromocytoma.</article-title>
                <source>Cancer Cell</source>
                <volume>8</volume>
                <fpage>91</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16098460</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.mcwhinney.2004.5694">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McWhinney</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilarski</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrester</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarquis</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dias</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Large germ-line deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>89</volume>
                <fpage>5694</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15531530</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.opocher.2006.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iacobone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toniato</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sattarova</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlic</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mian</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merante Boschin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambonin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Lazzari</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murgia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelizzo</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantero</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Familial nonsyndromic pheochromocytoma.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>149</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">17102081</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.qin.2010.229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buddavarapu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenci</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chocron</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lechleiter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aronin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boaretto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toledo</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toledo</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stiles</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguiar</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahia</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.</article-title>
                <source>Nat Genet</source>
                <volume>42</volume>
                <fpage>229</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">20154675</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.schiavi.2006.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savvoukidis</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trabalzini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grego</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piazza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amist&#x000e0;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dematt&#x000e8;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Piano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecchini</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlic</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Lazzari</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantero</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opocher</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1073</volume>
                <fpage>190</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17102086</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.simi.2005.e52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sestini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferruzzi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaglian&#x000f2;</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gensini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mascalchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pratesi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinzani</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nesi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ercolino</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genuardi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannelli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>e52</fpage>
                <pub-id pub-id-type="pmid">16061558</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.slane.2006.7615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Slane</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aykin-Burns</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalen</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goswami</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domann</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spitz</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutation of succinate dehydrogenase subunit C results in increased O2.-,oxidative stress, and genomic instability.</article-title>
                <source>Cancer Res</source>
                <volume>66</volume>
                <fpage>7615</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16885361</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.yip.2004.525">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yip</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shapiro</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waguespack</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoff</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagel</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arens</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DB</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Surgical management of hereditary pheochromocytoma.</article-title>
                <source>J Am Coll Surg</source>
                <volume>198</volume>
                <fpage>525</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15051000</pub-id>
              </element-citation>
            </ref>
            <ref id="paragangliomas.REF.young.2006.790">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Abboud</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Editorial: paraganglioma--all in the family.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>91</volume>
                <fpage>790</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">16522703</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="paragangliomas.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="paragangliomas.Author_History">
          <title>Author History</title>
          <p>Salman Kirmani, MBBS (2012-present)Roger D Klein, MD, JD; Blood Center of Wisconsin (2008-2012)Ricardo V Lloyd, MD, PhD; Mayo Clinic &#x02013; Rochester (2008-2012)William F Young, MD, MSc (2008-present)</p>
        </sec>
        <sec id="paragangliomas.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 November 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 August 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 September 2009 (cd) Revision: mutation in <italic toggle="yes">SDHAF2</italic> (<italic toggle="yes">SDH5)</italic> identified as causing PGL2</p>
            </list-item>
            <list-item>
              <p>7 April 2009 (cd) Revision: deletion/duplication analysis available clinically for <italic toggle="yes">SDHB, SDHC</italic> and <italic toggle="yes">SDHD</italic>; prenatal testing available for <italic toggle="yes">SDHB</italic></p>
            </list-item>
            <list-item>
              <p>23 September 2008 (cd) Revision: prenatal diagnosis for <italic toggle="yes">SDHC</italic> mutations available clinically</p>
            </list-item>
            <list-item>
              <p>21 May 2008 (me) Posted live</p>
            </list-item>
            <list-item>
              <p>14 November 2007 (rdk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
